HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 X64_SR12 18JUN21:06:47:1918JUN21:06:47:19 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SS SASDATA 9.4 X64_SR12 18JUN21:06:47:1918JUN21:06:47:19 Subject Status HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000001500000000000000000000 STUDYID Study Identifier DOMAIN Domain Abbreviation USUBJID Unique Subject Identifier SUBJID Subject Identifier for the Study )SSSEQ Sequence Number 2SSTESTCDStatus Short Name : SSTEST Status Name BSSCAT Category for Assessment b SSORRES Result or Finding Original Result m SSSTRESCCharacter Result/Finding in Std Format }VISITNUMVisit Number "VISIT Visit Name • EPOCH Epoch · SSDTC Date/Time of Assessment ËSSDY Study Day of Assessment Õ HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 mRNA-1273-P201SSmRNA-1273-P201-US201-1001US2011001ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1001US2011001A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1003US2011003ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1003US2011003A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BzmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-03-05C`mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BzmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-03-05C`mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BzmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-05C`mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BzmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1004US2011004B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-05C`mRNA-1273-P201SSmRNA-1273-P201-US201-1005US2011005ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1005US2011005A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1006US2011006ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1006US2011006A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1007US2011007B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1008US2011008ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1008US2011008A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1009US2011009B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-03B$mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-10B+mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-24B9mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-16B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-03B$mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-10B+mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-24B9mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-16B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27B[mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BumRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BïmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27B[mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BumRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BïmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27B[mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BumRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011B$COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BïmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27B[mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BumRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US201-1011US2011011B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BïmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B=mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B=mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BymRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23B‘mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BymRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23B‘mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BymRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23B‘mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BymRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23B‘mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US201-1012US2011012B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B;mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÝmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B;mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÝmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01B{mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01B{mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01B{mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01B{mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1014US2011014B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1015US2011015ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1015US2011015A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BzmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeBSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CàmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BzmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CàmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BzmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CàmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BzmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1018US2011018B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CàmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B;mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B;mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BxmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BxmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BxmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BxmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US201-1019US2011019B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B;mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÕmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B;mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÕmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BzmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BzmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BzmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BzmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1020US2011020B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1021US2011021ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1021US2011021A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1022US2011022ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1022US2011022A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B;mRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B;mRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US201-1023US2011023B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US201-1024US2011024ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1024US2011024A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1027US2011027ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1027US2011027A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028A COVID Exposed to COVID-19 Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-02-05BúmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCOVIDSYMParticipant COVID-19 Symptomatic N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-02-05BúmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BumRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÐmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BumRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÐmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BumRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B&COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÐmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BumRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1028US2011028B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÐmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C°mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C°mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C°mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1029US2011029B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C°mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1030US2011030B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BxmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-03-05CPmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BxmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-03-05CPmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BxmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-05CPmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BxmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US201-1032US2011032B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-05CPmRNA-1273-P201SSmRNA-1273-P201-US201-1033US2011033ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1033US2011033A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1034US2011034ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1034US2011034A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1035US2011035ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1035US2011035A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1037US2011037ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1037US2011037A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-09B¢mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-09B¢mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C°mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C°mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B&COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C°mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1039US2011039B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C°mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1040US2011040B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26B“mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-03-04C@mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26B“mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-03-04C@mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26B“mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041B"COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-04C@mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26B“mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US201-1041US2011041B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-04C@mRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁÀmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06BmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÛmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁÀmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06BmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÛmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BRmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BsmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-02BðmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-03-02CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BRmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BsmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-02BðmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-03-02CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BRmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BsmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-02BðmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-02CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BRmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BsmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-02BðmRNA-1273-P201SSmRNA-1273-P201-US201-1042US2011042B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-02CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043A COVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1043US2011043B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1045US2011045ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1045US2011045A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BzmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BzmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCONTACT Contact Attempted SAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BzmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046B#COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BzmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US201-1046US2011046B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B^mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B^mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B^mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B^mRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1048US2011048B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1049US2011049ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1049US2011049A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1050US2011050B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051ACOVID Exposed to COVID-19 N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÜmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÜmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B\mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-12B…mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BõmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01CmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B\mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-12B…mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BõmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01CmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B\mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-12B…mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BõmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B&COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01CmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B\mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-12B…mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BõmRNA-1273-P201SSmRNA-1273-P201-US201-1051US2011051B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01CmRNA-1273-P201SSmRNA-1273-P201-US201-1052US2011052ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1052US2011052A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1053US2011053ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1053US2011053A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1054US2011054ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1054US2011054A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÝmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÝmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1055US2011055B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1056US2011056B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1057US2011057B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÛmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÛmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BymRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BymRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BymRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BymRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US201-1059US2011059B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BwmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BwmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BwmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BwmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1060US2011060B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061A@COVID Exposed to COVID-19 Y Y A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061APCOVID Exposed to COVID-19 Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BVmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C°mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BVmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C°mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BVmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B&COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C°mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BVmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US201-1061US2011061B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C°mRNA-1273-P201SSmRNA-1273-P201-US201-1062US2011062ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1062US2011062A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1063US2011063ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1063US2011063A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B;mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B;mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BwmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BwmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BwmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BwmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B«mRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1064US2011064B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BxmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BxmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BxmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BxmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1065US2011065B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1066US2011066ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1066US2011066A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 .mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067APCOVID Exposed to COVID-19 N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BAmRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067A COVID Exposed to COVID-19 N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-10B¡mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÛmRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 .mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067AðCOVIDSYMParticipant COVID-19 Symptomatic Y Y A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCOVIDSYMParticipant COVID-19 Symptomatic N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BAmRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-10B¡mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÛmRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B\mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeA Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BwmRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27B“mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B¯mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BômRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B\mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BwmRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27B“mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B¯mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BômRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B\mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27B“mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B¯mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BômRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B\mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27B“mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B¯mRNA-1273-P201SSmRNA-1273-P201-US201-1067US2011067B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BômRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1068US2011068B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BzmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BzmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BzmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BzmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1069US2011069B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á€mRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 .mRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B?mRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á€mRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 .mRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US201-1070US2011070BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B?mRNA-1273-P201SSmRNA-1273-P201-US201-1071US2011071ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1071US2011071A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1072US2011072ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1072US2011072A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1074US2011074ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1074US2011074A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1075US2011075ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1075US2011075A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US201-1076US2011076ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US201-1076US2011076A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US201-1077US2011077ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US201-1077US2011077A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US201-1078US2011078ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US201-1078US2011078A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US201-1079US2011079ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US201-1079US2011079A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BñmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-03-02CmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BñmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-03-02CmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BñmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-02CmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BñmRNA-1273-P201SSmRNA-1273-P201-US201-1080US2011080B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-02CmRNA-1273-P201SSmRNA-1273-P201-US201-1083US2011083ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US201-1083US2011083A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1084US2011084B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-31BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-31BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BwmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-03-05C@mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BwmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-03-05C@mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BwmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B$COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B&COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-05C@mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BwmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US201-1085US2011085B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-05C@mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÛmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÛmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US201-1086US2011086B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BxmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26B’mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C°mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BxmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26B’mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C°mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BxmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26B’mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C°mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BxmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26B’mRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US201-1087US2011087B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C°mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B>mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÙmRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B>mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÙmRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B[mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BxmRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28B“mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B®mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-02BômRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25C°mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B[mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BxmRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28B“mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B®mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-02BômRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25C°mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B[mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BxmRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28B“mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B®mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-02BômRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25C°mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B[mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BxmRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28B“mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B®mRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-02BômRNA-1273-P201SSmRNA-1273-P201-US201-1088US2011088B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25C°mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089APCOVID Exposed to COVID-19 N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B$mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B+mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B5mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BCmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÙmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089AðCOVIDSYMParticipant COVID-19 Symptomatic Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B$mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B+mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B5mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BCmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÙmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BxmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-30B”mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B®mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BímRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BxmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-30B”mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B®mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BímRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BxmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-30B”mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B®mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BímRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B&COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BxmRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-30B”mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B®mRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BímRNA-1273-P201SSmRNA-1273-P201-US201-1089US2011089B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B9mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090A COVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-21BèmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B9mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-21BèmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BwmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BwmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BwmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B&COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BwmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US201-1090US2011090B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23CmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B=mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-24B®mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÚmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B=mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-24B®mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÚmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BVmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BwmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BVmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BwmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BVmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BwmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B$COVID Exposed to COVID-19 SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B&COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BVmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BwmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US201-1091US2011091B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B>mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÖmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B>mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÖmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BYmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BxmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27B‘mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BòmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01CàmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BYmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BxmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27B‘mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BòmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01CàmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BYmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BxmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27B‘mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BòmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01CàmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BYmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BxmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27B‘mRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BòmRNA-1273-P201SSmRNA-1273-P201-US201-1092US2011092B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01CàmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06BmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B9mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06BmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B9mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1093US2011093B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1094US2011094ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US201-1094US2011094A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B'mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÝmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B'mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÝmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BwmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B©mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BòmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01CàmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BwmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B©mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BòmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01CàmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BwmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B©mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BòmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B&COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01CàmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BwmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B©mRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BòmRNA-1273-P201SSmRNA-1273-P201-US201-1095US2011095B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01CàmRNA-1273-P201SSmRNA-1273-P201-US201-1096US2011096ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US201-1096US2011096A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US201-1097US2011097ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US201-1097US2011097A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US201-1098US2011098ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US201-1098US2011098A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US201-1099US2011099ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US201-1099US2011099A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US201-1100US2011100ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US201-1100US2011100A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US201-1101US2011101ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US201-1101US2011101A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06BmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÍmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06BmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÍmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BumRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01C°mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BumRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01C°mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BumRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102B$COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01C°mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BumRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US201-1102US2011102B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-01C°mRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÕmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÕmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BsmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BsmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BsmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BsmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US201-1103US2011103B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US201-1104US2011104ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US201-1104US2011104A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US201-1105US2011105ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US201-1105US2011105A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US201-1106US2011106ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US201-1106US2011106A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US201-1107US2011107ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US201-1107US2011107A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US201-1108US2011108ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US201-1108US2011108A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BamRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BxmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-02BúmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BamRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BxmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-02BúmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BamRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BxmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-02BúmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BamRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BxmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1109US2011109B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-02BúmRNA-1273-P201SSmRNA-1273-P201-US201-1111US2011111ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US201-1111US2011111A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US201-1112US2011112ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US201-1112US2011112A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B=mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B=mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-26BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-26BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-26BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-26BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1113US2011113B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BïmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-04BümRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-04BümRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-04BümRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1114US2011114B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-04BümRNA-1273-P201SSmRNA-1273-P201-US201-1115US2011115ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US201-1115US2011115A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÁðmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-27AmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B&mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B-mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B;mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÕmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÁðmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-27AmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B&mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B-mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B;mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÕmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25B[mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BtmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B«mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BòmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25B[mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BtmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B«mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BòmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25B[mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BtmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B«mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BòmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25B[mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BtmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B«mRNA-1273-P201SSmRNA-1273-P201-US201-1116US2011116B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BòmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BYmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BYmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BYmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BYmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1117US2011117B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28B_mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-04BümRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28B_mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-04BümRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28B_mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-04BümRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28B_mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1118US2011118B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-04BümRNA-1273-P201SSmRNA-1273-P201-US201-1119US2011119ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US201-1119US2011119A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15ÁÀmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-27AmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B&mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B-mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B;mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÕmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15ÁÀmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-27AmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B&mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B-mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B;mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÕmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B_mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BumRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B«mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-02BùmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B_mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BumRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B«mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-02BùmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B_mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BumRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B«mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-02BùmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B_mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BumRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B«mRNA-1273-P201SSmRNA-1273-P201-US201-1120US2011120B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-02BùmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121A€COVID Exposed to COVID-19 N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BZmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BZmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BZmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BZmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1121US2011121B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16Á mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122A`COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122ApCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122A€COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16Á mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122ACOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122A COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122A°COVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122AÀCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122AàCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122AðCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-05BýmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-05BýmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122B COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-05BýmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1122US2011122B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-05BýmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011025ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011025A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BamRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BamRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BamRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BamRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1123US2011123B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011081ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-29ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011081A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-29ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BYmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BYmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BYmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BYmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1124US2011124B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011017ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-26Â%mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁðmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B#mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÐmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011017A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-26Â%mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁðmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B#mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÐmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BZmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BZmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BZmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BZmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1125US2011125B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011038ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011038A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US201-1126US2011126B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011013ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-26ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127A COVID Exposed to COVID-19 N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-15BmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127AÀCOVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-02-08BämRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127AÐCOVID Exposed to COVID-19 N N AàQë…¸PVisit 8 Day 209 Unscheduled 2 PART A FOLLOW-UP 2021-03-09CmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011013AàCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-26ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127AðCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-15BmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-02-08BämRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AàQë…¸PVisit 8 Day 209 Unscheduled 2 PART A FOLLOW-UP 2021-03-09CmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BZmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B CONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-03-16C€mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B!CONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BZmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B"CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B#CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B$CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B%CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B&CONTACT Contact Attempted SAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B'CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-03-16C€mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B(COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BZmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B)COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B*COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B+COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B,COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B-COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B.COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-16C€mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BZmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B1COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B2COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B3COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B4COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US201-1127US2011127B5COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-03-16C€mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011047ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27Â"mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18ÁÀmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B,mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B:mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011047A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27Â"mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18ÁÀmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B,mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B:mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B\mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BsmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-25BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BïmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B\mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BsmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-25BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BïmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B\mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BsmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-25BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BïmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B\mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BsmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-25BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1128US2011128B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BïmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011073ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-28ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011073A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-28ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-26B]mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BõmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-26B]mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BõmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-26B]mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BõmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-26B]mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1130US2011130B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BõmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BvmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-05BýmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BvmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-05BýmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BvmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-05BýmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BvmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1131US2011131B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-05BýmRNA-1273-P201SSmRNA-1273-P201-US201-1132US2011026ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1132US2011132A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US201-1132US2011026A0COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1132US2011132A@COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US201-1133US2011133ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US201-1133US2011133A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US201-1134US2011134ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US201-1134US2011134A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US201-1135US2011135ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US201-1135US2011135A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US201-1136US2011136ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US201-1136US2011136A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011058ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-28ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-19B7mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011058A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-28ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-19B7mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-05BýmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-05BýmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-05BýmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24B[mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1137US2011137B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-03-05BýmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011031ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-27AmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B&mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B-mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B=mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÕmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011031A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-27AmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B&mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B-mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B=mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÕmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B_mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BvmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŒmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B«mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B_mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BvmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŒmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B«mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B_mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BvmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŒmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B«mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B_mRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BvmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŒmRNA-1273-P201SSmRNA-1273-P201-US201-1138US2011138B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B«mRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BZmRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BZmRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BZmRNA-1273-P201SSmRNA-1273-P201-US201-1139US2011139BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BZmRNA-1273-P201SSmRNA-1273-P201-US201-1140US2011016ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1140US2011140A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US201-1140US2011016A0COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1140US2011140A@COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011044ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27Â!mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22ÁpmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B&mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B;mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-28BÖmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011044A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27Â!mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22ÁpmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B&mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B;mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-28BÖmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-10-06BdmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-10-06BdmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-06BdmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-06BdmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1142US2011142B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1143US2011143ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US201-1143US2011143A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US201-1144US2011144ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US201-1144US2011144A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-20B8mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23Á0mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-20B8mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BYmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BYmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BYmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BYmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US201-1145US2011145B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1146US2011082ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US201-1146US2011146A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US201-1146US2011082A0COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US201-1146US2011146A@COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US201-1147US2011147ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US201-1147US2011147A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US201-1148US2011148ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US201-1148US2011148A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011010ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-26Â"mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B@mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011010A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-26Â"mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B@mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BWmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-26BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BWmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-26BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BWmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-26BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BWmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1149US2011149B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-26BÔmRNA-1273-P201SSmRNA-1273-P201-US201-1150US2011129ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US201-1150US2011150A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US201-1150US2011129A0COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US201-1150US2011150A@COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US201-1151US2011151ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US201-1151US2011151A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B@mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B@mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B]mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B]mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B]mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B]mRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US201-1152US2011152B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011141ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-06-22ÁpmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011141A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-06-22ÁpmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25Á@mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-25BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BðmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-25BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BðmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-25BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BðmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-25BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1153US2011153B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BðmRNA-1273-P201SSmRNA-1273-P201-US201-1154US2011002ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1154US2011154A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US201-1154US2011002A0COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1154US2011154A@COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B:mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B:mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B\mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-22BîmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B\mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-22BîmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B\mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-22BîmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B\mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1155US2011155B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-22BîmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B:mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B:mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B\mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BïmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B\mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BïmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B\mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BïmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29B\mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1156US2011156B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BïmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011110ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B;mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011110A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B;mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÒmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28B[mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BïmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28B[mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BïmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28B[mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BïmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28B[mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US201-1157US2011157B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BïmRNA-1273-P201SSmRNA-1273-P201-US201-1158US2011036ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1158US2011158A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1158US2011036A0COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US201-1158US2011158A@COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30Á mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30Á mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B9mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÑmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BZmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BumRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B¨mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BËmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BímRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BZmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BumRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B¨mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BËmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BímRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BZmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BumRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B¨mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BËmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BímRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BZmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BumRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B¨mRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BËmRNA-1273-P201SSmRNA-1273-P201-US201-1159US2011159B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-23BímRNA-1273-P201SSmRNA-1273-P201-US201-1160US2011160ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US201-1160US2011160A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US201-1161US2011161ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US201-1161US2011161A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-02-01BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01ÁPmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-02-01BÓmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BWmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-26BìmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BWmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-26BìmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BWmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-26BìmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BWmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US201-1162US2011162B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-26BìmRNA-1273-P201SSmRNA-1273-P201-US202-1001US2021001ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1001US2021001A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1002US2021002ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1002US2021002A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30B!mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B(mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B/mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-05BEmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÐmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30B!mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B(mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B/mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-05BEmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÐmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BYmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 293 PART A FOLLOW-UP 2021-03-15C0mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BYmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B#CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B$CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 293 PART A FOLLOW-UP 2021-03-15C0mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BYmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B)COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B*COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B+COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B,COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 293 PART A FOLLOW-UP 2021-03-15C0mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BYmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B1COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B2COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B3COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C mRNA-1273-P201SSmRNA-1273-P201-US202-1003US2021003B4COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 293 PART A FOLLOW-UP 2021-03-15C0mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-09AÀmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-09B*mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-24B9mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BËmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-09AÀmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-09B*mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-24B9mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BËmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-19BSmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-15CpmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-19BSmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-15CpmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-19BSmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-15CpmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-19BSmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1004US2021004B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-15CpmRNA-1273-P201SSmRNA-1273-P201-US202-1005US2021005ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1005US2021005A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US202-1005US2021005A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1005US2021005A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007A`COVID Exposed to COVID-19 N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B;mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007A COVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-06BCmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCOVIDSYMParticipant COVID-19 Symptomatic N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B;mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-06BCmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¬mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¬mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¬mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¬mRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1007US2021007B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1008US2021008ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1008US2021008A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1009US2021009ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1009US2021009A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-09B*mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-21B6mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BàmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-09B*mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-21B6mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BàmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1011US2021011B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1012US2021012B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US202-1013US2021013ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1013US2021013A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1014US2021014ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1014US2021014A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-09AÀmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-09B*mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-23B8mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-09AÀmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-09B*mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-23B8mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-19BSmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-12B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-19BìmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-19BSmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-12B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-19BìmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-19BSmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-12B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-19BìmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-19BSmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-12B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1015US2021015B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-19BìmRNA-1273-P201SSmRNA-1273-P201-US202-1017US2021017ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1017US2021017A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018APCOVID Exposed to COVID-19 N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-22B7mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018A€COVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-22B7mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-29B>mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BKmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29B×mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-22B7mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-22B7mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-29B>mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BKmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29B×mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1018US2021018B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-09AÀmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02B#mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B*mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B@mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-11BKmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÊmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019A°COVID Exposed to COVID-19 N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-01-26BómRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-09AÀmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02B#mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B*mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B@mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-11BKmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÊmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-01-26BómRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BZmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-19BìmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BZmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-19BìmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BZmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-19BìmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BZmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1019US2021019B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-19BìmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B;mRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-18BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B;mRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-18BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeAÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeAÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US202-1020US2021020B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-22B7mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BËmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-22B7mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BËmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-20BTmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-20BTmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-20BTmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-20BTmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1021US2021021B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B3mRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04BAmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÚmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B3mRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04BAmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÚmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-07BcmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-07BcmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-07BcmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-07BcmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1022US2021022B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1025US2021025ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1025US2021025A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1026US2021026ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1026US2021026A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1027US2021027ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1027US2021027A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1028US2021028ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1028US2021028A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1030US2021030ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1030US2021030A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-18BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-18BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1031US2021031B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US202-1032US2021032ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1032US2021032A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US202-1032US2021032A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1032US2021032A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US202-1033US2021033ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1033US2021033A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1034US2021034ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1034US2021034A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US202-1034US2021034A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1034US2021034A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US202-1036US2021036ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1036US2021036A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1037US2021037ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1037US2021037A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1038US2021038ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1038US2021038A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1041US2021041ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1041US2021041A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US202-1041US2021041A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1041US2021041A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02B mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B/mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B;mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02B mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B/mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B;mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BXmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1043US2021043B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B@mRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-02B›mRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045A COVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-30B·mRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B@mRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-02B›mRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-30B·mRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1045US2021045B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-24B6mRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-24B6mRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1047US2021047B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BðmRNA-1273-P201SSmRNA-1273-P201-US202-1048US2021048ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1048US2021048A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1049US2021049ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1049US2021049A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1050US2021050ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1050US2021050A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1051US2021051ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1051US2021051A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1052US2021052ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1052US2021052A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1053US2021053ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1053US2021053A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1053US2021053A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1053US2021053A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1054US2021054ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1054US2021054A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1055US2021055ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1055US2021055A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1055US2021055A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1055US2021055A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1056US2021056ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1056US2021056A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1056US2021056A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1056US2021056A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1057US2021057ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1057US2021057A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058ApCOVID Exposed to COVID-19 N N AP(õÂ$Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B1mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCOVIDSYMParticipant COVID-19 Symptomatic N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B1mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1058US2021058B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B<mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÇmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B<mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÇmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1059US2021059B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1060US2021060ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1060US2021060A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1060US2021060A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1060US2021060A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÝmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÝmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1061US2021061B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á€mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062A`COVID Exposed to COVID-19 Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062ApCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B6mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-31BÓmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062AÀCOVID Exposed to COVID-19 Y Y Aà(õÂ$Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á€mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062AàCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062AðCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B6mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-31BÓmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BSmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BSmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B!CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B"CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BSmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BSmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1062US2021062B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á€mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B?mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BËmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063A COVID Exposed to COVID-19 N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á€mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B?mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BËmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B\mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BîmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B\mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BîmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B\mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BîmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B\mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1063US2021063B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BîmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁÀmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064A`COVID Exposed to COVID-19 Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064ApCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B9mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064A°COVID Exposed to COVID-19 Y Y AÀ(õÂ$Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064AÀCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁÀmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064AàCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064AðCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCOVIDSYMParticipant COVID-19 Symptomatic N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B9mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B CONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B!CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B"CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B#CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B$CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B%CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B&CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B'COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B(COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B)COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B*COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B+COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B,COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B-COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B1COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B2COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B3COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1064US2021064B4COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1065US2021065ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1065US2021065A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1065US2021065A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1065US2021065A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1066US2021066ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1066US2021066A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1066US2021066A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1066US2021066A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B?mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÊmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B?mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÊmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BZmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BZmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BZmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BZmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1067US2021067B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BémRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BémRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1068US2021068B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1069US2021069ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1069US2021069A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1071US2021071ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1071US2021071A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1071US2021071A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1071US2021071A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1072US2021072ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1072US2021072A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1072US2021072A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1072US2021072A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B<mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073A COVID Exposed to COVID-19 Y Y AÀQë…¸PSafety Call Day 169 Unscheduled 2 PART A FOLLOW-UP 2020-12-09B¿mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÛmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073AÀCOVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-07BÜmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B<mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀQë…¸PSafety Call Day 169 Unscheduled 2 PART A FOLLOW-UP 2020-12-09B¿mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÛmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-07BÜmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B!CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B"CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B#CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B$CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B(COVID Exposed to COVID-19 SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B)COVID Exposed to COVID-19 SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B*COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1073US2021073B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BámRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BámRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B\mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B\mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B\mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B\mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1074US2021074B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1075US2021075ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1075US2021075A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1075US2021075A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1075US2021075A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1077US2021077ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1077US2021077A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AàmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B:mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AàmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B:mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1078US2021078B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US202-1079US2021079ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1079US2021079A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1079US2021079A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1079US2021079A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á€mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B0mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B@mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á€mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B0mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B@mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BímRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BímRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BímRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1080US2021080B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BímRNA-1273-P201SSmRNA-1273-P201-US202-1081US2021081ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1081US2021081A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07BBmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082ACOVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-10BdmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082A COVID Exposed to COVID-19 N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-08B€mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07BBmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-10BdmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-08B€mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B\mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B\mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B\mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B\mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US202-1082US2021082B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1083US2021083ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1083US2021083A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1083US2021083A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1083US2021083A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á€mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÚmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á€mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÚmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1084US2021084B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1085US2021085ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1085US2021085A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1086US2021086ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1086US2021086A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1087US2021087ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1087US2021087A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1087US2021087A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1087US2021087A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1088US2021088ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1088US2021088A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US202-1088US2021088A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1088US2021088A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á°mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á°mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1089US2021089B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A°mRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B1mRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B<mRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÙmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A°mRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B1mRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B<mRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÙmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-07BbmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeA°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÇmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-07BbmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÇmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-07BbmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÇmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-07BbmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US202-1090US2021090B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÇmRNA-1273-P201SSmRNA-1273-P201-US202-1091US2021091ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1091US2021091A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1092US2021092ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1092US2021092A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BAmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÌmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BAmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÌmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-11BemRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-11BemRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-11BemRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-11BemRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US202-1093US2021093B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á€mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AàmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094A`COVID Exposed to COVID-19 Y Y APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094ApCOVID Exposed to COVID-19 Y Y AP(õÂ$Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 PART A FOLLOW-UP 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 PART A FOLLOW-UP 2020-07-17B+mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B?mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094A°COVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094AÀCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÑmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á€mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094AàCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094AðCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AàmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCOVIDSYMParticipant COVID-19 Symptomatic Y Y APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 PART A FOLLOW-UP 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 PART A FOLLOW-UP 2020-07-17B+mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B?mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÑmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B!CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B"CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B#CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B$CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B)COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B*COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1094US2021094B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US202-1095US2021095ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1095US2021095A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1095US2021095A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1095US2021095A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B7mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÙmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B7mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÙmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-15B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-15B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-15B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-15B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US202-1096US2021096B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US202-1097US2021097ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1097US2021097A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1097US2021097A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1097US2021097A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1098US2021098ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1098US2021098A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1098US2021098A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1098US2021098A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A°mRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099ACOVID Exposed to COVID-19 Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-07BCmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A°mRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-07BCmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B"CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B)COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US202-1099US2021099B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-18C`mRNA-1273-P201SSmRNA-1273-P201-US202-1100US2021100ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1100US2021100A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1100US2021100A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1100US2021100A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á°mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B.mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÇmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á°mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B.mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÇmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B"CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B)COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1101US2021101B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US202-1102US2021102ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1102US2021102A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1102US2021102A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1102US2021102A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1103US2021103ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1103US2021103A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1105US2021105ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1105US2021105A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1105US2021105A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1105US2021105A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107A`COVID Exposed to COVID-19 Y Y A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B7mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107ACOVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-11BemRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BØmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B7mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-11BemRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BØmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1107US2021107B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US202-1108US2021108ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1108US2021108A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1109US2021109ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1109US2021109A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US202-1109US2021109A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1109US2021109A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US202-1110US2021110ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1110US2021110A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US202-1110US2021110A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1110US2021110A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111A`COVID Exposed to COVID-19 Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111ApCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-30B5mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-17BGmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÓmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111AÀCOVID Exposed to COVID-19 N N Aà(õÂ$Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-25BèmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111AàCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111AðCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-30B5mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-17BGmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÓmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-25BèmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B!CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B"CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B#CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B$CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B)COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B*COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1111US2021111B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1112US2021112ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1112US2021112A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1113US2021113ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1113US2021113A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US202-1113US2021113A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1113US2021113A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BumRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BumRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BumRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BumRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US202-1114US2021114B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B2mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B@mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÌmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B2mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B@mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÌmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1115US2021115B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1116US2021116ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1116US2021116A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1117US2021117ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1117US2021117A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1118US2021118ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1118US2021118A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1119US2021119ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1119US2021119A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1119US2021119A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1119US2021119A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1120US2021120ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1120US2021120A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1120US2021120A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1120US2021120A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B@mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÑmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121A COVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-31BÔmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B@mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÑmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-31BÔmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1121US2021121B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US202-1122US2021122ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1122US2021122A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1123US2021123ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1123US2021123A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US202-1123US2021123A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1123US2021123A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US202-1124US2021124ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1124US2021124A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1124US2021124A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1124US2021124A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1125US2021125ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1125US2021125A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1125US2021125A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1125US2021125A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1126US2021126ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1126US2021126A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1127US2021127ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1127US2021127A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1128US2021128ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1128US2021128A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1128US2021128A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1128US2021128A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1129US2021129ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1129US2021129A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B0mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B?mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B0mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B?mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1130US2021130B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1131US2021131ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1131US2021131A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1131US2021131A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1131US2021131A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1132US2021132ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1132US2021132A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B1mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B?mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B1mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B?mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-10B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-10B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-10B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-10B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1133US2021133B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1134US2021134ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1134US2021134A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÀmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÀmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US202-1135US2021135B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US202-1136US2021136ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1136US2021136A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1136US2021136A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1136US2021136A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01ÁpmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137ACOVID Exposed to COVID-19 N N Ap(õÂ$Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-11BAmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18BHmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-31BÏmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01ÁpmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCOVIDSYMParticipant COVID-19 Symptomatic N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-11BAmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18BHmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-31BÏmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B!CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B"CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B#CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B$CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B)COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B*COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B+COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B1COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1137US2021137B2COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÀmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B!mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B/mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BDmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138A COVID Exposed to COVID-19 Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-02-08BúmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÀmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B!mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B/mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BDmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-02-08BúmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B[mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B[mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B[mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B[mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1138US2021138B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US202-1139US2021139ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1139US2021139A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1140US2021140ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1140US2021140A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1141US2021141ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1141US2021141A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1142US2021142ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1142US2021142A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1143US2021143ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1143US2021143A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1143US2021143A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1143US2021143A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144A€COVID Exposed to COVID-19 Y Y Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-07-31B9mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BCmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÖmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCOVIDSYMParticipant COVID-19 Symptomatic N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-07-31B9mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BCmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÖmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B"CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B)COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1144US2021144B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B1mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BFmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145ACOVID Exposed to COVID-19 Y Y AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BàmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B1mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BFmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BàmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BbmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C€mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BbmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C€mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BbmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C€mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BbmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US202-1145US2021145B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C€mRNA-1273-P201SSmRNA-1273-P201-US202-1146US2021146ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1146US2021146A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B*mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B0mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-09B¼mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B*mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B0mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-09B¼mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1147US2021147B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1148US2021148ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1148US2021148A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US202-1148US2021148A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1148US2021148A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US202-1149US2021149ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1149US2021149A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1150US2021150ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1150US2021150A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US202-1150US2021150A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1150US2021150A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-18A°mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-25BmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151A€COVID Exposed to COVID-19 Y Y A`(õÂ$Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-23B.mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B9mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÚmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-18A°mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-25BmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-23B.mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B9mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÚmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1151US2021151B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US202-1152US2021152ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1152US2021152A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1153US2021153ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1153US2021153A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US202-1153US2021153A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1153US2021153A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B2mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BCmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-13BƒmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B2mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BCmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-13BƒmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09BamRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1154US2021154B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-29B4mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BBmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-17BGmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155A COVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-23BlmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÖmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-29B4mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BBmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-17BGmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-23BlmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÖmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155B!CONTACT Contact Attempted SAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155B&COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1155US2021155B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1156US2021156ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1156US2021156A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1156US2021156A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1156US2021156A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1157US2021157ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1157US2021157A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1157US2021157A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1157US2021157A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1158US2021158ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1158US2021158A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1158US2021158A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1158US2021158A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1159US2021159ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1159US2021159A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1160US2021160ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1160US2021160A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÍmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÍmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1161US2021161B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 PART A FOLLOW-UP 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 PART A FOLLOW-UP 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 PART A FOLLOW-UP 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162A`COVID Exposed to COVID-19 N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 PART A FOLLOW-UP 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 PART A FOLLOW-UP 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 PART A FOLLOW-UP 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÜmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 PART A FOLLOW-UP 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 PART A FOLLOW-UP 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 PART A FOLLOW-UP 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCOVIDSYMParticipant COVID-19 Symptomatic N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 PART A FOLLOW-UP 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 PART A FOLLOW-UP 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 PART A FOLLOW-UP 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÜmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BdmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-30B°mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BdmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-30B°mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B"CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BdmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-30B°mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B)COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BdmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-30B°mRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1162US2021162B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1163US2021163ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1163US2021163A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164A0COVID Exposed to COVID-19 N N A (õÂ\(Visit 1 Day 1 Unscheduled 1 BLINDED TREATMENT 2020-06-10A0mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B2mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164A COVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-14BmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÜmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164AàCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Visit 1 Day 1 Unscheduled 1 BLINDED TREATMENT 2020-06-10A0mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B2mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-14BmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÜmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-22B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-22B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-22B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-22B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1164US2021164B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US202-1165US2021165ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1165US2021165A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B1mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BámRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166A COVID Exposed to COVID-19 N N B\(õÃSafety Call Day 265 Unscheduled 1 PART A FOLLOW-UP 2021-03-18CðmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B1mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BámRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCOVIDSYMParticipant COVID-19 Symptomatic N N B\(õÃSafety Call Day 265 Unscheduled 1 PART A FOLLOW-UP 2021-03-18CðmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B"CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B)COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US202-1166US2021166B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÓmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÓmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-30B°mRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-30B°mRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-30B°mRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-30B°mRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1167US2021167B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1168US2021168ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1168US2021168A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1169US2021169ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1169US2021169A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1170US2021170ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1170US2021170A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1170US2021170A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1170US2021170A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1171US2021171ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1171US2021171A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1172US2021172ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1172US2021172A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US202-1173US2021173ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1173US2021173A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1174US2021174ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1174US2021174A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US202-1174US2021174A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1174US2021174A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B9mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-13B€mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175A COVID Exposed to COVID-19 N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-13BŸmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÕmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B9mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-13B€mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-13BŸmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÕmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1175US2021175B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1176US2021176ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1176US2021176A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US202-1177US2021177ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1177US2021177A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US202-1177US2021177A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1177US2021177A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US202-1178US2021178ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1178US2021178A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-08B{mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÍmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179A°COVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-06BÕmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-08B{mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÍmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-06BÕmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1179US2021179B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B=mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08B×mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B=mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08B×mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1180US2021180B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1181US2021181ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1181US2021181A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B6mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B6mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BêmRNA-1273-P201SSmRNA-1273-P201-US202-1182US2021182B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24C`mRNA-1273-P201SSmRNA-1273-P201-US202-1183US2021183ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1183US2021183A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US202-1184US2021184ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US202-1184US2021184A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-08AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B5mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÌmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185A°COVID Exposed to COVID-19 Y Y Aà(õÂ$Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-02-09BåmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-08AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B5mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÌmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-02-09BåmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1185US2021185B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B1mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B1mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1186US2021186B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1187US2021187ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US202-1187US2021187A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US202-1188US2021188ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US202-1188US2021188A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-30B¼mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÏmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-30B¼mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÏmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeA°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1189US2021189B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B0mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190A COVID Exposed to COVID-19 Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-03-02BúmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B0mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCOVIDSYMParticipant COVID-19 Symptomatic N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-03-02BúmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1190US2021190B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US202-1191US2021191ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US202-1191US2021191A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-30BžmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-30BžmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1192US2021192B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1193US2021193ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US202-1193US2021193A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US202-1194US2021194ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US202-1194US2021194A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US202-1194US2021194A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US202-1194US2021194A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US202-1195US2021195ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US202-1195US2021195A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B)mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B0mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B=mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B)mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B0mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B=mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1196US2021196B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1197US2021197ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US202-1197US2021197A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15ÁàmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B3mRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01BAmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15ÁàmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B3mRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01BAmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1198US2021198B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1199US2021199ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US202-1199US2021199A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US202-1201US2021201ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US202-1201US2021201A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US202-1202US2021006ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1202US2021006A COVID Exposed to COVID-19 N N ?(õÂ$öPrevious Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US202-1202US2021202A0COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US202-1202US2021202A@COVID Exposed to COVID-19 N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US202-1202US2021006APCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US202-1202US2021006A`COVIDSYMParticipant COVID-19 Symptomatic N N ?(õÂ$öPrevious Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US202-1202US2021202ApCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US202-1202US2021202A€COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US202-1203US2021203ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US202-1203US2021203A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US202-1203US2021203A0COVID Exposed to COVID-19 N N AQë…¸RScreening Unscheduled 2 SCREENING 2020-07-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1203US2021203A@COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US202-1203US2021203APCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US202-1203US2021203A`COVIDSYMParticipant COVID-19 Symptomatic N N AQë…¸RScreening Unscheduled 2 SCREENING 2020-07-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1204US2021204ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US202-1204US2021204A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021035ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205A°COVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-02-03BßmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021035AÀCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-02-03BßmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-16BìmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-16BìmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-16BìmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1205US2021205B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-16BìmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021029ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-26Â%mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021029A COVID Exposed to COVID-19 N N ?(õÂ\(öPrevious Screening Unscheduled 1 SCREENING 2020-06-01ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206A0COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁðmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206A@COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206APCOVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206A`COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206ApCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04B"mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B1mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BEmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206A°COVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-16BMmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206AÀCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021029AÐCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-26Â%mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021029AàCOVIDSYMParticipant COVID-19 Symptomatic N N ?(õÂ\(öPrevious Screening Unscheduled 1 SCREENING 2020-06-01ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206AðCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁðmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04B"mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B1mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BEmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-16BMmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BomRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BomRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B!CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B"CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BomRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BRmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BomRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1206US2021206B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021104ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-28ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021104A COVID Exposed to COVID-19 N N ?(õÂ\(öPrevious Screening Unscheduled 1 SCREENING 2020-06-01ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207A0COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207A@COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207APCOVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207A`COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207ApCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B1mRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B7mRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03BFmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207A°COVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-23BZmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207AÀCOVID Exposed to COVID-19 N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207AÐCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÐmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021104AàCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-28ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021104AðCOVIDSYMParticipant COVID-19 Symptomatic N N ?(õÂ\(öPrevious Screening Unscheduled 1 SCREENING 2020-06-01ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B1mRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B7mRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03BFmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-23BZmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÐmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B CONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B!CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B"CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B#CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B$CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B)COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1207US2021207B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021044ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27Â#mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁàmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208A0COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-24ÁpmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208A@COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208APCOVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208A`COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208ApCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208A€COVID Exposed to COVID-19 N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208ACOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B)mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208A COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B2mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208A°COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BFmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208AÀCOVID Exposed to COVID-19 N N AÀ(õÂ$Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2021-01-07B¿mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208AÐCOVID Exposed to COVID-19 Y Y AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021044AàCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27Â#mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208AðCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁàmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-24ÁpmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13AÐmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B)mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B2mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BFmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2021-01-07B¿mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BpmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B CONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B!CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BpmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B"CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B#CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B$CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BpmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B)COVID Exposed to COVID-19 SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BpmRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US202-1208US2021208B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1209US2021046ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1209US2021209A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US202-1209US2021209A0COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US202-1209US2021046A@COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1209US2021209APCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US202-1209US2021209A`COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US202-1210US2021042ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1210US2021042A COVID Exposed to COVID-19 N N ?(õÂ$öPrevious Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US202-1210US2021210A0COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US202-1210US2021210A@COVID Exposed to COVID-19 N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US202-1210US2021042APCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US202-1210US2021042A`COVIDSYMParticipant COVID-19 Symptomatic N N ?(õÂ$öPrevious Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US202-1210US2021210ApCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US202-1210US2021210A€COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021010ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-26Â%mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18ÁàmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B7mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021010A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-26Â%mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18ÁàmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B7mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BSmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BSmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BSmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BSmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1211US2021211B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1212US2021212ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US202-1212US2021212A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US202-1213US2021076ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1213US2021076A COVID Exposed to COVID-19 N N ?(õÂ\(öPrevious Screening Unscheduled 1 SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US202-1213US2021213A0COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US202-1213US2021076A@COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US202-1213US2021076APCOVIDSYMParticipant COVID-19 Symptomatic N N ?(õÂ\(öPrevious Screening Unscheduled 1 SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US202-1213US2021213A`COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021040ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021040A COVID Exposed to COVID-19 N N ?(õÂ\(öPrevious Screening Unscheduled 1 SCREENING 2020-06-01ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214A0COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214A@COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214APCOVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214A`COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214ApCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-20B8mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214A°COVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-11BNmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214AÀCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021040AÐCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021040AàCOVIDSYMParticipant COVID-19 Symptomatic N N ?(õÂ\(öPrevious Screening Unscheduled 1 SCREENING 2020-06-01ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214AðCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-20B8mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-11BNmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B!CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B"CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B#CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B$CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B)COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B*COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1214US2021214B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-15BëmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021070ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27Â!mRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á°mRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A°mRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B4mRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BHmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215A COVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-08BHmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÌmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021070AÀCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27Â!mRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á°mRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A°mRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B4mRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BHmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-08BHmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÌmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeA°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US202-1215US2021215B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021039ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-27Â$mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021039A COVID Exposed to COVID-19 N N ?(õÂ$öPrevious Screening Unscheduled 1 SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216A0COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19ÁÐmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216A@COVID Exposed to COVID-19 N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-26Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216APCOVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216A`COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216ApCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216A€COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216ACOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B(mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216A COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216A°COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216AÀCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021039AÐCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-27Â$mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021039AàCOVIDSYMParticipant COVID-19 Symptomatic N N ?(õÂ$öPrevious Screening Unscheduled 1 SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216AðCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19ÁÐmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-26Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B(mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-22BìmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B!CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B"CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B#CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B$CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-22BìmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B)COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B*COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-22BìmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1216US2021216B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-22BìmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021200ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-06-15ÁàmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19Á mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217A0COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217A@COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217APCOVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217A`COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217ApCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B(mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B;mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021200AÀCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-06-15ÁàmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19Á mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217AàCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217AðCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B(mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B;mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1217US2021217B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021106ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-28Â!mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23ÁpmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B'mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B-mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218A COVID Exposed to COVID-19 Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-12BimRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BËmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021106AÀCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-28Â!mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23ÁpmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B'mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B-mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-12BimRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BËmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-18BêmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-18BêmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-18BêmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1218US2021218B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-18BêmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021024ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-26Â#mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021024A COVID Exposed to COVID-19 N N ?(õÂ\(öPrevious Screening Unscheduled 1 SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219A0COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23ÁpmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219A@COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219APCOVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219A`COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219ApCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B*mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219ACOVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219A COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B.mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219A°COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03BBmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219AÀCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÌmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021024AÐCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-26Â#mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021024AàCOVIDSYMParticipant COVID-19 Symptomatic N N ?(õÂ\(öPrevious Screening Unscheduled 1 SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219AðCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23ÁpmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B*mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B.mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03BBmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÌmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BTmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BrmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-18BêmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BTmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BrmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B!CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B"CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B#CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B$CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-18BêmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BTmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BrmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B)COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B*COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-18BêmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BTmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BrmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1219US2021219B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-18BêmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021016ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-26Â"mRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021016A COVID Exposed to COVID-19 N N ?(õÂ\(öPrevious Screening Unscheduled 1 SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220A0COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220A@COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220APCOVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220A`COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220ApCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B(mRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021016AÀCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-26Â"mRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021016AÐCOVIDSYMParticipant COVID-19 Symptomatic N N ?(õÂ\(öPrevious Screening Unscheduled 1 SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220AàCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220AðCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B(mRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BêmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BêmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BêmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1220US2021220B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BêmRNA-1273-P201SSmRNA-1273-P201-US202-1221US2021221ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1221US2021221A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1221US2021221A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1221US2021221A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021023ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AàmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B(mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B7mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021023A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29Á0mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AàmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B(mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B7mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BSmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BSmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BSmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BSmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1222US2021222B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1223US2021223ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1223US2021223A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US202-1224US2021224ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US202-1224US2021224A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US202-1225US2021225ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US202-1225US2021225A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1225US2021225A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US202-1225US2021225A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226A`COVID Exposed to COVID-19 N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-08-05BmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-14B(mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226ACOVID Exposed to COVID-19 N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226A°COVID Exposed to COVID-19 Y Y AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-08-05BmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-14B(mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCOVIDSYMParticipant COVID-19 Symptomatic N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-24BêmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-24BêmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B'COVID Exposed to COVID-19 SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-24BêmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1226US2021226B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-24BêmRNA-1273-P201SSmRNA-1273-P201-US202-1227US2021227ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1227US2021227A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1228US2021228ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1228US2021228A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US202-1228US2021228A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1228US2021228A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US202-1229US2021229ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1229US2021229A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US202-1229US2021229A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US202-1229US2021229A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B(mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2021-01-06B¹mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230A COVID Exposed to COVID-19 N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 PART A FOLLOW-UP 2021-02-05B×mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-02-15BámRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B(mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B<mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2021-01-06B¹mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCOVIDSYMParticipant COVID-19 Symptomatic N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 PART A FOLLOW-UP 2021-02-05B×mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-02-15BámRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US202-1230US2021230B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1231US2021231ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1231US2021231A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1231US2021231A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1231US2021231A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-02Á@mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-15A mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-06B mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B'mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-10BCmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-10BCmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232A COVID Exposed to COVID-19 Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-13BdmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-02Á@mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-15A mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-06B mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B'mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-10BCmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-10BCmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-13BdmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US202-1232US2021232B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US202-1233US2021233ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1233US2021233A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1233US2021233A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-02.mRNA-1273-P201SSmRNA-1273-P201-US202-1233US2021233A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-02ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14A€mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AàmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B$mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B*mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B;mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-02ÁPmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14A€mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AàmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B$mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B*mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B;mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÄmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BTmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BpmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22B©mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BTmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BpmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22B©mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BTmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BpmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22B©mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BTmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BpmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BŒmRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22B©mRNA-1273-P201SSmRNA-1273-P201-US202-1234US2021234B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-20BÆmRNA-1273-P201SSmRNA-1273-P201-US202-1235US2021235ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1235US2021235A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1236US2021236ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1236US2021236A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1237US2021237ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1237US2021237A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1238US2021238ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1238US2021238A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1239US2021239ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1239US2021239A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US202-1240US2021240ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US202-1240US2021240A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US202-1241US2021241ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US202-1241US2021241A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30B!mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B(mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B0mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B>mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÏmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30B!mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B(mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B0mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B>mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÏmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BZmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BZmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BZmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BZmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1001US2031001B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B(mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B/mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B(mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B/mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1002US2031002B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1003US2031003ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1003US2031003A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1003US2031003A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1003US2031003A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004A`COVID Exposed to COVID-19 N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-01B"mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B(mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B1mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03BCmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004A COVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-04B mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCOVIDSYMParticipant COVID-19 Symptomatic N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-01B"mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B(mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B1mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03BCmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-04B mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27B[mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BqmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27B[mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BqmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27B[mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BqmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27B[mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BqmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1004US2031004B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1005US2031005ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1005US2031005A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1006US2031006ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1006US2031006A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1007US2031007ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1007US2031007A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1007US2031007A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1007US2031007A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1008US2031008ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1008US2031008A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1009US2031009B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1010US2031010ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1010US2031010A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1010US2031010A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1010US2031010A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01B"mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B)mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B1mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05BEmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011ACOVID Exposed to COVID-19 Y Y AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BàmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011A COVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-07BàmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01B"mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B)mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B1mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05BEmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BàmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-07BàmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-15CpmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B"CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-15CpmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B)COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-15CpmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1011US2031011B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-15CpmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1012US2031012B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013A COVID Exposed to COVID-19 N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-02-02BömRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCOVIDSYMParticipant COVID-19 Symptomatic N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-02-02BömRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BWmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1013US2031013B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BËmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BËmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1014US2031014B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1015US2031015ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1015US2031015A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26ÁmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B6mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016A COVID Exposed to COVID-19 Y Y A (õÂ$Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-08BmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26ÁmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B6mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-08BmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C€mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B!CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B"CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B#CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B$CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C€mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B)COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B*COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B+COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C€mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B1COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1016US2031016B2COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C€mRNA-1273-P201SSmRNA-1273-P201-US203-1017US2031017ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1017US2031017A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1017US2031017A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1017US2031017A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1018US2031018ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1018US2031018A COVID Exposed to COVID-19 N N AQë…¸RScreening Unscheduled 2 SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1018US2031018A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1018US2031018A@COVIDSYMParticipant COVID-19 Symptomatic N N AQë…¸RScreening Unscheduled 2 SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02B#mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B+mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B2mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B?mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29B×mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02B#mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B+mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B2mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B?mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29B×mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-30B^mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BxmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-30B^mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BxmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-30B^mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BxmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-30B^mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BxmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1019US2031019B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01B"mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B0mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03BCmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01B"mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B0mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03BCmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BwmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BwmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BwmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BwmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1020US2031020B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B.mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B<mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B.mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B<mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021B!COVID Exposed to COVID-19 SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1021US2031021B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1022US2031022B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02B#mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B*mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B1mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02B#mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B*mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B1mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28B\mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28B\mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28B\mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023B#COVID Exposed to COVID-19 SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28B\mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1023US2031023B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1024US2031024ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1024US2031024A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1024US2031024A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1024US2031024A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1025US2031025ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1025US2031025A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B(mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-24B9mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÝmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B(mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-24B9mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÝmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BqmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BqmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BqmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BqmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1026US2031026B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B<mRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B<mRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1027US2031027B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1028US2031028ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1028US2031028A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÌmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÌmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31B[mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31B[mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31B[mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31B[mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1029US2031029B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-29BXmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-29BXmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-29BXmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-29BXmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1030US2031030B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1031US2031031ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1031US2031031A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1031US2031031A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1031US2031031A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1032US2031032ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1032US2031032A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B:mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033A°COVID Exposed to COVID-19 N N Aà(õÂ$Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B:mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1033US2031033B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US203-1034US2031034ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1034US2031034A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035A€COVID Exposed to COVID-19 Y Y A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035ACOVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-14BjmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-14BjmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1035US2031035B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1036US2031036ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1036US2031036A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1036US2031036A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1036US2031036A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÙmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÙmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¥mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¥mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¥mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¥mRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1037US2031037B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B:mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BØmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B:mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BØmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C`mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B"CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C`mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B)COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C`mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1038US2031038B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C`mRNA-1273-P201SSmRNA-1273-P201-US203-1039US2031039ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1039US2031039A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040A COVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B"CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B)COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1040US2031040B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041ApCOVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B;mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B;mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BsmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BsmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BsmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BsmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1041US2031041B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á€mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B!mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B(mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B=mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á€mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B!mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B(mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B=mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1042US2031042B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á€mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B9mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á€mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B9mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1043US2031043B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1044US2031044ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1044US2031044A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1044US2031044A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1044US2031044A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1045US2031045ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1045US2031045A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1045US2031045A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1045US2031045A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1045US2031045APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 .mRNA-1273-P201SSmRNA-1273-P201-US203-1045US2031045A`COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1045US2031045ApCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1045US2031045A€COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1045US2031045ACOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1045US2031045A COVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 .mRNA-1273-P201SSmRNA-1273-P201-US203-1046US2031046ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1046US2031046A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047A`COVID Exposed to COVID-19 N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCOVIDSYMParticipant COVID-19 Symptomatic N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1047US2031047B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B/mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B<mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B/mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B<mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1048US2031048B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BtmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1049US2031049B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AàmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AàmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C`mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B"CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C`mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B)COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C`mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1050US2031050B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C`mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1051US2031051B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1052US2031052ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1052US2031052A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1053US2031053ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1053US2031053A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1054US2031054ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1054US2031054A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1055US2031055ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1055US2031055A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US203-1055US2031055A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1055US2031055A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BWmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1056US2031056B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057ACOVID Exposed to COVID-19 Y Y A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B:mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B:mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1057US2031057B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B=mRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B=mRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BRmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1058US2031058B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US203-1059US2031059ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1059US2031059A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B7mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060A COVID Exposed to COVID-19 Y Y AÀ(õÂ$Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B7mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BVmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BVmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BVmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BVmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1060US2031060B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1061US2031061ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1061US2031061A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B7mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B7mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BVmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BVmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BVmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BVmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1062US2031062B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B'mRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B'mRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1063US2031063B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1064US2031064ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1064US2031064A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1064US2031064A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1064US2031064A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1065US2031065ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1065US2031065A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1065US2031065A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1065US2031065A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-13B¥mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-13B¥mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1066US2031066B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1067US2031067ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1067US2031067A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1067US2031067A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1067US2031067A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1068US2031068ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1068US2031068A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1068US2031068A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1068US2031068A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1069US2031069ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1069US2031069A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1069US2031069A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1069US2031069A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1070US2031070ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1070US2031070A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B:mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-18BÆmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B:mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-18BÆmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BTmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BTmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BTmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BTmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1071US2031071B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B)mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B3mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07BBmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072A COVID Exposed to COVID-19 N N AÀ(õÂ$Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BËmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B)mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B3mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07BBmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BËmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-23BRmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-23BRmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-23BRmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-23BRmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1072US2031072B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÝmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÝmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-23BSmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-23BSmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-23BSmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-23BSmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1073US2031073B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074APCOVID Exposed to COVID-19 N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074AðCOVIDSYMParticipant COVID-19 Symptomatic Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1074US2031074B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US203-1075US2031075ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1075US2031075A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1076US2031076ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1076US2031076A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1077US2031077ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1077US2031077A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1078US2031078ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1078US2031078A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B:mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B:mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-29BWmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C€mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-29BWmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C€mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-29BWmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C€mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-29BWmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1079US2031079B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C€mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÐmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B@mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-06B}mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080A COVID Exposed to COVID-19 Y Y AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÐmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B@mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-06B}mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1080US2031080B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B=mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081ACOVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B=mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1081US2031081B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US203-1082US2031082ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US203-1082US2031082A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US203-1082US2031082A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US203-1082US2031082A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US203-1083US2031083ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US203-1083US2031083A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08Á mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A€mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AÐmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B$mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B+mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B9mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05ÁPmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08Á mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A€mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AÐmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B$mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B+mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B9mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BUmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BomRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B§mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BêmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BUmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BomRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B§mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BêmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BUmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BomRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B§mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BêmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BUmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BomRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B§mRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1084US2031084B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BêmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085ApCOVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B>mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B>mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1085US2031085B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086ACOVID Exposed to COVID-19 N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1086US2031086B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1087US2031087ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US203-1087US2031087A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US203-1088US2031088ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US203-1088US2031088A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B1mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B?mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B1mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B?mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1089US2031089B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1090US2031090ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US203-1090US2031090A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1091US2031091B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-18ÁÀmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B-mRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-18ÁÀmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B-mRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BTmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BpmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BTmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BpmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BTmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BpmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BTmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BpmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1092US2031092B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16ÁðmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AàmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-04BBmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16ÁðmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AàmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-04BBmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BWmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BpmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BWmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BpmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BWmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BpmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BWmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BpmRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1093US2031093B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-22ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AÀmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B6mRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-22ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AÀmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B6mRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1095US2031095B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1096US2031096B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16ÁàmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B#mRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B*mRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B.mRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02BAmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-28BÕmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16ÁàmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B#mRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B*mRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B.mRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02BAmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-28BÕmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BVmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BpmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BVmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BpmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BVmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BpmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BVmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BpmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1097US2031097B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B(mRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B/mRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÆmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B(mRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B/mRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÆmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US203-1098US2031098B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1099US2031099ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US203-1099US2031099A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US203-1099US2031099A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US203-1099US2031099A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AàmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B"mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B,mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B2mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B@mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÌmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AàmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B"mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B,mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B2mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B@mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÌmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¤mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¤mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¤mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¤mRNA-1273-P201SSmRNA-1273-P201-US203-1100US2031100B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B3mRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01BAmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B3mRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01BAmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BêmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BêmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BêmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1101US2031101B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BêmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-17ÁðmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B)mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B0mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102A COVID Exposed to COVID-19 N N A(õÂ$Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-17ÁðmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B)mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B0mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B£mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B£mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B£mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B£mRNA-1273-P201SSmRNA-1273-P201-US203-1102US2031102B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30B mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103ApCOVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B<mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30B mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B<mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1103US2031103B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B2mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B2mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1104US2031104B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1105US2031105B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-02ApmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106ApCOVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B?mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-02-01BÝmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-02ApmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B?mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-02-01BÝmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1106US2031106B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02BBmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÌmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02BBmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÌmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1107US2031107B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-23BmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B'mRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B.mRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B6mRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-23BmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B'mRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B.mRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B6mRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BRmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BnmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1108US2031108B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1109US2031109B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B>mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B>mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US203-1110US2031110B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B1mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-02-01BÝmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B1mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-02-01BÝmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1111US2031111B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112A`COVID Exposed to COVID-19 N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02BEmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCOVIDSYMParticipant COVID-19 Symptomatic N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02BEmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US203-1112US2031112B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1113US2031113ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US203-1113US2031113A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B,mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B:mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÆmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B,mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B:mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÆmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1114US2031114B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US203-1115US2031115ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US203-1115US2031115A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US203-1115US2031115A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US203-1115US2031115A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A°mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30B mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B/mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B=mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116ACOVID Exposed to COVID-19 Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-14BlmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÆmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A°mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30B mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B/mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B=mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-14BlmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÆmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1116US2031116B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1117US2031117ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US203-1117US2031117A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US203-1118US2031118ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US203-1118US2031118A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US203-1119US2031119ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US203-1119US2031119A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US203-1119US2031119A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US203-1119US2031119A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US203-1120US2031120ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US203-1120US2031120A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16ÁàmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B*mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B8mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121A COVID Exposed to COVID-19 Y Y A (õÂ$Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-26BwmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121A°COVID Exposed to COVID-19 N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-24B”mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121AÀCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121AàCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-16ÁàmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121AðCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B*mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B8mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-26BwmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-24B”mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BrmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BrmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B!CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B"CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BrmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BrmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US203-1121US2031121B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1122US2031122B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1123US2031123ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US203-1123US2031123A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁÀmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁÀmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BsmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BsmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BsmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BsmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1124US2031124B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125A COVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19ÁpmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-13BnmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-13BnmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-13BnmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-13BnmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1125US2031125B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1126US2031126ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US203-1126US2031126A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US203-1127US2031094ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US203-1127US2031127A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US203-1127US2031127A0COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US203-1127US2031094A@COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US203-1127US2031127APCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US203-1127US2031127A`COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23Á€mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B+mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B9mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23Á€mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AðmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B+mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B9mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1128US2031128B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129ApCOVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B;mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÆmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25Á`mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B;mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÆmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16B‹mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US203-1129US2031129B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US203-1130US2031130ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US203-1130US2031130A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1130US2031130A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US203-1130US2031130A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B9mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29Á0mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B9mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÅmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BTmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BTmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BTmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BTmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BnmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŠmRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¦mRNA-1273-P201SSmRNA-1273-P201-US203-1131US2031131B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US203-1132US2031132ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1132US2031132A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US203-1133US2031133ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-02.mRNA-1273-P201SSmRNA-1273-P201-US203-1133US2031133A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-02.mRNA-1273-P201SSmRNA-1273-P201-US203-1134US2031134ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US203-1134US2031134A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US203-1135US2031135ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US203-1135US2031135A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US203-1136US2031136ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US203-1136US2031136A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US204-1001US2041001ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1001US2041001A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1001US2041001A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1001US2041001A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002B$COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1002US2041002B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 293 PART A FOLLOW-UP 2021-04-01CmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 321 PART A FOLLOW-UP 2021-04-21C@mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B!CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B"CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 293 PART A FOLLOW-UP 2021-04-01CmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B#CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 321 PART A FOLLOW-UP 2021-04-21C@mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B$COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B%COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B&COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B'COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B)COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B*COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 293 PART A FOLLOW-UP 2021-04-01CmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B+COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 321 PART A FOLLOW-UP 2021-04-21C@mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B1COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22C mRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B2COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 293 PART A FOLLOW-UP 2021-04-01CmRNA-1273-P201SSmRNA-1273-P201-US204-1003US2041003B3COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 321 PART A FOLLOW-UP 2021-04-21C@mRNA-1273-P201SSmRNA-1273-P201-US204-1004US2041004ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1004US2041004A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-10B+mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B=mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005ACOVID Exposed to COVID-19 N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-10B+mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B=mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-19C°mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-19C°mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005B"COVID Exposed to COVID-19 SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-19C°mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1005US2041005B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-19C°mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B;mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B;mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BnmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BnmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BnmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BnmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1006US2041006B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÌmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÌmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BomRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BomRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007B CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 321 .mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BomRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BomRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US204-1007US2041007B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BHmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BHmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BSmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BomRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BSmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BomRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BSmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BomRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BSmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BomRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1008US2041008B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1009US2041009ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1009US2041009A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1009US2041009A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1009US2041009A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B(mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B/mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B(mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B/mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BYmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C°mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BYmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C°mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BYmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010B%COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C°mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BYmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US204-1010US2041010B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C°mRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-17BNmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-17BNmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BomRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BomRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BomRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011B%COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BomRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1011US2041011B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B4mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BBmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BËmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B4mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BBmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BËmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BRmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BRmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BRmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BRmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1012US2041012B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B)mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B0mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B)mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B0mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 321 .mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013B%COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BXmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US204-1013US2041013B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B)mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-21B6mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B)mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-21B6mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-19BrmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US204-1014US2041014B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US204-1015US2041015ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1015US2041015A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1015US2041015A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1015US2041015A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BHmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016ACOVID Exposed to COVID-19 Y Y AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016A COVID Exposed to COVID-19 N N AÐQë…¸PSafety Call Day 197 Unscheduled 2 PART A FOLLOW-UP 2021-01-11BàmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BHmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCOVIDSYMParticipant COVID-19 Symptomatic N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCOVIDSYMParticipant COVID-19 Symptomatic N N AÐQë…¸PSafety Call Day 197 Unscheduled 2 PART A FOLLOW-UP 2021-01-11BàmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1016US2041016B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1017US2041017ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1017US2041017A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1018US2041018ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1018US2041018A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BHmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BHmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1019US2041019B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á€mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B@mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á€mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B@mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B"COVID Exposed to COVID-19 SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1020US2041020B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1021US2041021ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1021US2041021A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B=mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-05BšmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022A COVID Exposed to COVID-19 N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-03B¶mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÏmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B=mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-05BšmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-03B¶mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÏmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-29BVmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-29BVmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-29BVmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-29BVmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1022US2041022B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-06B€mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-06B€mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeAÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1023US2041023B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B7mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024A COVID Exposed to COVID-19 Y Y A (õÂ$Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÙmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-01Á mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B7mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÙmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B$COVID Exposed to COVID-19 SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1024US2041024B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025B$COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BVmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1025US2041025B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1026US2041026B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027A COVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-08B¿mRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027A°COVID Exposed to COVID-19 Y Y AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-08B¿mRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BsmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BsmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B"CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BsmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B'COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BsmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1027US2041027B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1028US2041028ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1028US2041028A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1028US2041028A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1028US2041028A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B%mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029B%COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US204-1029US2041029B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030ApCOVID Exposed to COVID-19 Y Y ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030A€COVID Exposed to COVID-19 N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCOVIDSYMParticipant COVID-19 Symptomatic Y Y ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCOVIDSYMParticipant COVID-19 Symptomatic N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B!CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B"CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B'COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B(COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1030US2041030B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1031US2041031ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1031US2041031A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1031US2041031A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1031US2041031A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1032US2041032ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1032US2041032A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1032US2041032A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1032US2041032A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1033US2041033ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1033US2041033A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02B mRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B/mRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05BBmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02B mRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B/mRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05BBmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-28BxmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B!CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B"CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B'COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B(COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1034US2041034B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-17C`mRNA-1273-P201SSmRNA-1273-P201-US204-1035US2041035ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1035US2041035A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1035US2041035A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1035US2041035A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036ACOVID Exposed to COVID-19 Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-10BFmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036A COVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-10BFmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B#CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B$COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B%COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B&COVID Exposed to COVID-19 SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B'COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B(COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B)COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1036US2041036B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1037US2041037ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1037US2041037A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1038US2041038ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1038US2041038A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1039US2041039ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1039US2041039A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US204-1040US2041040ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1040US2041040A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A°mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B/mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B@mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A°mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B/mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B@mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041B$COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B«mRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1041US2041041B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A°mRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B/mRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B@mRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A°mRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B/mRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B@mRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-12BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-12BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042B$COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-12BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-12BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1042US2041042B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-20BêmRNA-1273-P201SSmRNA-1273-P201-US204-1043US2041043ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1043US2041043A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1043US2041043A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1043US2041043A@COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1043US2041043APCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1043US2041043A`COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1044US2041044ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1044US2041044A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1045US2041045ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1045US2041045A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AÐmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B>mRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AÐmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B>mRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-11BEmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20BªmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-11BEmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20BªmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-11BEmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20BªmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-11BEmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20BªmRNA-1273-P201SSmRNA-1273-P201-US204-1046US2041046B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047ACOVID Exposed to COVID-19 Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-13BImRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047A COVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-09BdmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-13BImRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-09BdmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BsmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BsmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047B CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BsmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BsmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1047US2041047B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B?mRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048A COVID Exposed to COVID-19 N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-01-28BñmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B?mRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-01-28BñmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048B CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1048US2041048B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-22B1mRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-28B7mRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BEmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-22B1mRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-28B7mRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BEmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-08-30BXmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-30BXmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049B COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1049US2041049B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US204-1050US2041050ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1050US2041050A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1051US2041051B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1052US2041052ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1052US2041052A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1052US2041052A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1052US2041052A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B4mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BFmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BËmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B4mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BFmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BËmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BRmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BRmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BRmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053B$COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BRmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1053US2041053B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1054US2041054ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1054US2041054A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1055US2041055ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1055US2041055A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1055US2041055A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1055US2041055A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-25BmRNA-1273-P201SSmRNA-1273-P201-US204-1055US2041055APCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1055US2041055A`COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1055US2041055ApCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1055US2041055A€COVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-25BmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B;mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B;mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1056US2041056B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1057US2041057ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1057US2041057A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US204-1057US2041057A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1057US2041057A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US204-1058US2041058ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1058US2041058A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1058US2041058A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1058US2041058A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US204-1058US2041058APCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US204-1058US2041058A`COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1058US2041058ApCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1058US2041058A€COVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US204-1059US2041059ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1059US2041059A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1059US2041059A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A mRNA-1273-P201SSmRNA-1273-P201-US204-1059US2041059A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US204-1059US2041059APCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1059US2041059A`COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1059US2041059ApCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A mRNA-1273-P201SSmRNA-1273-P201-US204-1059US2041059A€COVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18BNmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18BNmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B$COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B&COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US204-1060US2041060B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-24CÀmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B3mRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-13BImRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÛmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B3mRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-13BImRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÛmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BRmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BRmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BRmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-22BRmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1061US2041061B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1062US2041062B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BðmRNA-1273-P201SSmRNA-1273-P201-US204-1063US2041063ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1063US2041063A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1064US2041064ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á°mRNA-1273-P201SSmRNA-1273-P201-US204-1064US2041064A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1064US2041064A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US204-1064US2041064A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US204-1064US2041064APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US204-1064US2041064A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US204-1064US2041064ApCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á°mRNA-1273-P201SSmRNA-1273-P201-US204-1064US2041064A€COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1064US2041064ACOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US204-1064US2041064A COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US204-1064US2041064A°COVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US204-1064US2041064AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US204-1065US2041065ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1065US2041065A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1066US2041066ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1066US2041066A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US204-1066US2041066A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1066US2041066A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US204-1067US2041067ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1067US2041067A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US204-1067US2041067A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1067US2041067A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US204-1068US2041068ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1068US2041068A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US204-1069US2041069ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1069US2041069A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1070US2041070ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1070US2041070A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1070US2041070A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1070US2041070A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A°mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07BCmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÝmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A°mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07BCmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÝmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B!CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1071US2041071B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C°mRNA-1273-P201SSmRNA-1273-P201-US204-1072US2041072ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1072US2041072A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-05B~mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-05B~mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1073US2041073B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1074US2041074ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1074US2041074A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075B"COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1075US2041075B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05BAmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-13BImRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÌmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05BAmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-13BImRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÌmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076B!CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1076US2041076B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B&mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B7mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B&mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B7mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B$COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B&COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BrmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1077US2041077B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-23C mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B&mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B;mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B&mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B;mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B!CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B&COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B'COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B(COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US204-1078US2041078B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B4mRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079A€COVID Exposed to COVID-19 Y Y A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07BBmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B4mRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07BBmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1079US2041079B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B8mRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080A COVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-05BÙmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080A°COVID Exposed to COVID-19 N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-02-08BûmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B%mRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B8mRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-05BÙmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCOVIDSYMParticipant COVID-19 Symptomatic N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-02-08BûmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1080US2041080B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BïmRNA-1273-P201SSmRNA-1273-P201-US204-1081US2041081ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1081US2041081A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US204-1081US2041081A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1081US2041081A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US204-1082US2041082ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1082US2041082A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1083US2041083ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1083US2041083A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B?mRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084ACOVID Exposed to COVID-19 Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-09BbmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B?mRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-09BbmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20BªmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20BªmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20BªmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20BªmRNA-1273-P201SSmRNA-1273-P201-US204-1084US2041084B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US204-1085US2041085ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US204-1085US2041085A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US204-1085US2041085A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US204-1085US2041085A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06BmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B=mRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06BmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B=mRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BRmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BRmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BRmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BRmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1086US2041086B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1087US2041087ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US204-1087US2041087A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B!mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B2mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088ACOVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088A COVID Exposed to COVID-19 N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B!mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B2mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-14BcmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1088US2041088B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B!mRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B=mRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÔmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B!mRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B=mRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÔmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1089US2041089B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B!mRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B2mRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÓmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B!mRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B2mRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÓmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BnmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1090US2041090B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08Á mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A€mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24AðmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10BmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B)mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B0mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B>mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091A COVID Exposed to COVID-19 Y Y A(õÂ$Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-25BlmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÑmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-08Á mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A€mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24AðmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10BmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B)mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B0mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B>mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-25BlmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÑmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BTmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BomRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-23BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BTmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BomRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-23BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091B!CONTACT Contact Attempted SAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BTmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091B#COVID Exposed to COVID-19 SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BomRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091B&COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-23BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BTmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BomRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1091US2041091B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-23BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B2mRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÌmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B2mRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÌmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BRmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BRmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BRmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BRmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1092US2041092B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-01BïmRNA-1273-P201SSmRNA-1273-P201-US204-1093US2041093ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US204-1093US2041093A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-20B8mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-08ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-20B8mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-10B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-10B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-10B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-10B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1094US2041094B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1095US2041095ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US204-1095US2041095A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US204-1095US2041095A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US204-1095US2041095A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BsmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BsmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCONTACT Contact Attempted SAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BsmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BsmRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1096US2041096B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US204-1097US2041097ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US204-1097US2041097A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US204-1098US2041098ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US204-1098US2041098A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US204-1099US2041099ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US204-1099US2041099A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A°mRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A°mRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BWmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BWmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BWmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100B"COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BWmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US204-1100US2041100B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1101US2041101ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US204-1101US2041101A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US204-1101US2041101A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US204-1101US2041101A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeA Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeA°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102B COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1102US2041102B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16Á mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16Á mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103B"COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1103US2041103B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1104US2041104B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1105US2041105ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US204-1105US2041105A COVID Exposed to COVID-19 N N A (õÂ\(Visit 1 Day 1 Unscheduled 1 SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1105US2041105A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US204-1105US2041105A@COVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Visit 1 Day 1 Unscheduled 1 SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCONTACT Contact Attempted SAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1106US2041106B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeA Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeA°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107B COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1107US2041107B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-14BQmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-14BQmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-12BªmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-12BªmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B!CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-12BªmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B&COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B'COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-12BªmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1108US2041108B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1109US2041109B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1110US2041110ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US204-1110US2041110A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US204-1110US2041110A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US204-1110US2041110A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AÀmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B<mRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AÀmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B<mRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111B"COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US204-1111US2041111B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01BDmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01BDmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1112US2041112B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19Á°mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B&mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B-mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113A COVID Exposed to COVID-19 N N A€(õÂ$Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-17BPmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113A°COVID Exposed to COVID-19 Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-16BmmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113AÀCOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-12-03BmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113AÐCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÓmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113AàCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113AðCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-19Á°mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B&mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B-mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-17BPmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-16BmmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-12-03BmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÓmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08BemRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B CONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08BemRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B!CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B"CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B#CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B$CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B%CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B&COVID Exposed to COVID-19 SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08BemRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B'COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B(COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B)COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B*COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08BemRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US204-1113US2041113B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-07AÀmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01BDmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÏmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-07AÀmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01BDmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÏmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1114US2041114B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04B#mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B*mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B1mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B>mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115ACOVID Exposed to COVID-19 Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-05BamRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04B#mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B*mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B1mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B>mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-05BamRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BpmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BpmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BpmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BpmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US204-1115US2041115B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1116US2041116ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US204-1116US2041116A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US204-1116US2041116A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US204-1116US2041116A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1117US2041117B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A°mRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B&mRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÌmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A°mRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B&mRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÌmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeAÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1118US2041118B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B:mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-14BGmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B:mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-14BGmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B«mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B«mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B«mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1119US2041119B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B«mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B*mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B8mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÏmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B*mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B8mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÏmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120B COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1120US2041120B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AàmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B8mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AàmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B8mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCONTACT Contact Attempted SAFETY CALLN N A Safety Call Day 113 .mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 .mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 .mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1121US2041121B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BWmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BWmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BWmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BWmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1122US2041122B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123ApCOVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123A COVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B"CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B#CONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B$COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B%COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B&COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1123US2041123B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1124US2041124ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US204-1124US2041124A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16ÁÐmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16ÁÐmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BêmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCONTACT Contact Attempted SAFETY CALLN N A Safety Call Day 113 .mRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BêmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 .mRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BêmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 .mRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US204-1125US2041125B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BêmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B2mRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B@mRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÐmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B2mRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B@mRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÐmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126B COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1126US2041126B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127B"COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1127US2041127B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1128US2041128ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US204-1128US2041128A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US204-1129US2041129ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US204-1129US2041129A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US204-1129US2041129A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US204-1129US2041129A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-07AÀmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-07AÀmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¯mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¯mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCONTACT Contact Attempted SAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¯mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¯mRNA-1273-P201SSmRNA-1273-P201-US204-1130US2041130B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15ÁàmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-17B2mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-15BOmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15ÁàmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-17B2mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-15BOmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1131US2041131B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÒmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÒmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-14BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-14BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-14BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132B!COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-14BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1132US2041132B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1133US2041133ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US204-1133US2041133A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US204-1133US2041133A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US204-1133US2041133A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US204-1134US2041134ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US204-1134US2041134A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US204-1134US2041134A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US204-1134US2041134A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US204-1135US2041135ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US204-1135US2041135A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B"mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B)mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B1mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B?mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÊmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B"mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B)mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B1mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B?mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÊmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BWmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-16BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BWmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-16BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BWmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-16BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BWmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1136US2041136B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-16BÈmRNA-1273-P201SSmRNA-1273-P201-US204-1137US2041137ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US204-1137US2041137A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16Á mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16Á mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-10B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-10B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCONTACT Contact Attempted SAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-10B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138B"COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-10B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1138US2041138B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16ÁÐmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16ÁÐmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 293 .mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BVmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US204-1139US2041139B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¬mRNA-1273-P201SSmRNA-1273-P201-US204-1140US2041140ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US204-1140US2041140A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1140US2041140A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US204-1140US2041140A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1141US2041141ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US204-1141US2041141A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US204-1141US2041141A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US204-1141US2041141A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-22Á mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142A°COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-22Á mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-26BWmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeA Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BumRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-26BWmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BumRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-26BWmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BumRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-26BWmRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BumRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US204-1142US2041142B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1143US2041143ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US204-1143US2041143A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16Á mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16Á mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeAÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÄmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US204-1144US2041144B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-17BímRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AàmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145A°COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AàmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-10-08BcmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08BcmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCONTACT Contact Attempted SAFETY CALLN N AÀSafety Call Day 169 .mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08BcmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08BcmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1145US2041145B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-16BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13AÀmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B8mRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁðmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13AÀmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B8mRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08BcmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08BcmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08BcmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08BcmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1146US2041146B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18BªmRNA-1273-P201SSmRNA-1273-P201-US204-1147US2041147ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US204-1147US2041147A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US204-1147US2041147A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US204-1147US2041147A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US204-1148US2041148ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US204-1148US2041148A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25Á°mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-15A mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B&mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B-mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B;mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25Á°mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-15A mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B&mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B-mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B;mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22BªmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22BªmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22BªmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149B"COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22BªmRNA-1273-P201SSmRNA-1273-P201-US204-1149US2041149B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18ÁÐmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B"mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B,mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B3mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B@mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÌmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18ÁÐmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AðmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B"mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B,mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B3mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B@mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÌmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-09-26BXmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeA Safety Call Day 113 PART A FOLLOW-UP 2020-10-24BtmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-26BXmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-24BtmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-26BXmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-24BtmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-26BXmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-24BtmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17BªmRNA-1273-P201SSmRNA-1273-P201-US204-1150US2041150B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-02Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B:mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-02Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B:mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÆmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22BªmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05B¸mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22BªmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05B¸mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCONTACT Contact Attempted SAFETY CALLN N BSafety Call Day 265 .mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22BªmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05B¸mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22BªmRNA-1273-P201SSmRNA-1273-P201-US204-1151US2041151B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-05B¸mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-02ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14A€mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21AðmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B&mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B-mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B;mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19ÂmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-02ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14A€mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21AðmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B&mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B-mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B;mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÇmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B^mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BqmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-19BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BêmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B^mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BqmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-19BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BêmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B^mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BqmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152B$COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-19BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BêmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B^mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BqmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-19BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1152US2041152B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BêmRNA-1273-P201SSmRNA-1273-P201-US204-1153US2041153ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US204-1153US2041153A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US204-1154US2041154ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US204-1154US2041154A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-02Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-02Á@mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22BªmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22BªmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22BªmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1155US2041155B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-22BªmRNA-1273-P201SSmRNA-1273-P201-US204-1156US2041156ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1156US2041156A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1157US2041157ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1157US2041157A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US204-1158US2041158ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US204-1158US2041158A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US204-1159US2041159ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US204-1159US2041159A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US204-1160US2041160ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US204-1160US2041160A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US204-1161US2041161ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1161US2041161A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1162US2041162ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1162US2041162A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1163US2041163ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1163US2041163A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1164US2041164ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1164US2041164A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1165US2041165ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1165US2041165A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01ÁPmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCONTACT Contact Attempted SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166B COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-10-08B_mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BrmRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 .mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US204-1166US2041166B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÂmRNA-1273-P201SSmRNA-1273-P201-US204-1167US2041167ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1167US2041167A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1168US2041168ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1168US2041168A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US204-1169US2041169ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-02.mRNA-1273-P201SSmRNA-1273-P201-US204-1169US2041169A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-02.mRNA-1273-P201SSmRNA-1273-P201-US204-1170US2041170ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US204-1170US2041170A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US204-1171US2041171ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US204-1171US2041171A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US204-1172US2041172ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US204-1172US2041172A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-07.mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26ÁmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÐmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B*mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B8mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-18BÆmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001A COVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-11BÞmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26ÁmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÐmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B*mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B8mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-18BÆmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-11BÞmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BémRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BémRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001B$COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BémRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1001US2051001B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BémRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B'mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B'mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1002US2051002B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-06-30B!mRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-10B+mRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B=mRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-06-30B!mRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-10B+mRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B=mRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeA Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeAÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-12B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-15BnmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-12B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US205-1003US2051003BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1004US2051004ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US205-1004US2051004A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US205-1004US2051004A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US205-1004US2051004A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US205-1005US2051005ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US205-1005US2051005A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US205-1005US2051005A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US205-1005US2051005A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US205-1006US2051006ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US205-1006US2051006A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US205-1006US2051006A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US205-1006US2051006A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US205-1007US2051007ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US205-1007US2051007A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US205-1007US2051007A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US205-1007US2051007A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30B!mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÖmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AðmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30B!mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÖmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-16BomRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-16BomRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-16BomRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-18BRmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-16BomRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-13BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-10B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1008US2051008B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-18BëmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÍmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÍmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1009US2051009B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-02B{mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-18BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-02B{mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-18BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1010US2051010B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B:mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B:mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19BªmRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1011US2051011B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B'mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B'mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1012US2051012B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B)mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÌmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B)mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÌmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeAðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1013US2051013B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1014US2051014ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US205-1014US2051014A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US205-1014US2051014A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US205-1014US2051014A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US205-1015US2051015ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US205-1015US2051015A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US205-1015US2051015A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US205-1015US2051015A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US205-1016US2051016ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US205-1016US2051016A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US205-1016US2051016A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US205-1016US2051016A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AàmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B7mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AàmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B7mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BRmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B»mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BRmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B»mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BRmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B»mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BRmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B»mRNA-1273-P201SSmRNA-1273-P201-US205-1017US2051017B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁÀmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B;mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁÀmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B;mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¹mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¹mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¹mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¹mRNA-1273-P201SSmRNA-1273-P201-US205-1018US2051018B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁÐmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16A€mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AàmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B%mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B*mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B?mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÙmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁÐmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16A€mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AàmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B%mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B*mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B?mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÙmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BUmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BrmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-30B¯mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BëmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BUmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BrmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-30B¯mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BëmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BUmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BrmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-30B¯mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BëmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BUmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BrmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BmRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-30B¯mRNA-1273-P201SSmRNA-1273-P201-US205-1019US2051019B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BëmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AàmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B=mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AàmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B=mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BémRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BémRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BémRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1020US2051020B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BémRNA-1273-P201SSmRNA-1273-P201-US205-1021US2051021ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US205-1021US2051021A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US205-1021US2051021A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US205-1021US2051021A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B½mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B½mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B½mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B½mRNA-1273-P201SSmRNA-1273-P201-US205-1022US2051022B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1023US2051023ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US205-1023US2051023A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US205-1023US2051023A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US205-1023US2051023A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BËmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BËmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1024US2051024B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AàmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B#mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B*mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B1mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B8mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÞmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AàmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B#mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B*mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B1mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B8mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÞmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10B½mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BîmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10B½mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BîmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10B½mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BîmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10B½mRNA-1273-P201SSmRNA-1273-P201-US205-1025US2051025B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BîmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B@mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÆmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1026US2051026B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B6mRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B6mRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10BºmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10BºmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10BºmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24BªmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10BºmRNA-1273-P201SSmRNA-1273-P201-US205-1027US2051027B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÀmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 PART A FOLLOW-UP 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028A`COVID Exposed to COVID-19 N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 PART A FOLLOW-UP 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 PART A FOLLOW-UP 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 PART A FOLLOW-UP 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B6mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÀmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 PART A FOLLOW-UP 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCOVIDSYMParticipant COVID-19 Symptomatic N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 PART A FOLLOW-UP 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 PART A FOLLOW-UP 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 PART A FOLLOW-UP 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B6mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BémRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BémRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BémRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1028US2051028B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BémRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B/mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B9mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-29B”mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÊmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B/mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B9mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-29B”mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÊmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1029US2051029B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B?mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030ACOVID Exposed to COVID-19 Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-08-31BZmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B?mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-08-31BZmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-10B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1030US2051030B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BËmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BËmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1031US2051031B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032A`COVID Exposed to COVID-19 N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCOVIDSYMParticipant COVID-19 Symptomatic N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1032US2051032B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AàmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033A`COVID Exposed to COVID-19 N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B7mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033A COVID Exposed to COVID-19 Y Y AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÑmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AàmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCOVIDSYMParticipant COVID-19 Symptomatic N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B7mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCOVIDSYMParticipant COVID-19 Symptomatic N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÑmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BRmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BnmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B¼mRNA-1273-P201SSmRNA-1273-P201-US205-1033US2051033B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034A@COVID Exposed to COVID-19 N N A0(õÂ\(Visit 2 Day 8 Unscheduled 1 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B)mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034AÐCOVIDSYMParticipant COVID-19 Symptomatic Y Y A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0(õÂ\(Visit 2 Day 8 Unscheduled 1 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B)mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B½mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B½mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B½mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B½mRNA-1273-P201SSmRNA-1273-P201-US205-1034US2051034B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AàmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B#mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B*mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B9mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035ACOVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-03B\mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035A COVID Exposed to COVID-19 N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-02BymRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÊmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AàmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B#mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B*mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B9mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-03B\mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-02BymRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÊmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B#COVID Exposed to COVID-19 SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B$COVID Exposed to COVID-19 SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1035US2051035B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A mRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B'mRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B<mRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-18BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A mRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B'mRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B<mRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-18BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BtmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1036US2051036B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US205-1037US2051037ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US205-1037US2051037A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US205-1038US2051038ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1038US2051038A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1038US2051038A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1038US2051038A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AàmRNA-1273-P201SSmRNA-1273-P201-US205-1038US2051038APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1038US2051038A`COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1038US2051038ApCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1038US2051038A€COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1038US2051038ACOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AàmRNA-1273-P201SSmRNA-1273-P201-US205-1038US2051038A COVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US205-1039US2051039ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US205-1039US2051039A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US205-1039US2051039A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US205-1039US2051039A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040A`COVID Exposed to COVID-19 N N A@(õÂ$Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040ApCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B>mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÑmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCOVIDSYMParticipant COVID-19 Symptomatic N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B>mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÑmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BímRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BímRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BímRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1040US2051040B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BímRNA-1273-P201SSmRNA-1273-P201-US205-1041US2051041ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US205-1041US2051041A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042A COVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B:mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-29BÓmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-09B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1042US2051042B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BêmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043APCOVID Exposed to COVID-19 Y Y APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B7mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-16BˆmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B7mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-16BˆmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B½mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B½mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B½mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BSmRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-08B½mRNA-1273-P201SSmRNA-1273-P201-US205-1043US2051043B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BêmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B*mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B6mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B*mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B6mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BRmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÁmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BRmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÁmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BRmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÁmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BRmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BnmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÁmRNA-1273-P201SSmRNA-1273-P201-US205-1044US2051044B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08Á mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A€mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24AðmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B%mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B*mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B8mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045A°COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08Á mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A€mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24AðmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B%mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B*mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B8mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BVmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BqmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14BmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B©mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeAðSafety Call Day 237 PART A FOLLOW-UP 2021-02-03BïmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BVmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BqmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14BmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B©mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-03BïmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BVmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BqmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14BmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B©mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BVmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BqmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14BmRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B©mRNA-1273-P201SSmRNA-1273-P201-US205-1045US2051045B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1046US2051046ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US205-1046US2051046A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US205-1047US2051047ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US205-1047US2051047A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US205-1047US2051047A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US205-1047US2051047A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05Á@mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16A€mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-25BmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B%mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B1mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B:mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05Á@mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16A€mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-25BmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B%mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B1mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B:mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BTmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BpmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-12B»mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BêmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BTmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BpmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-12B»mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BêmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BTmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BpmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-12B»mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BêmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BTmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BpmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-12B»mRNA-1273-P201SSmRNA-1273-P201-US205-1048US2051048B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BêmRNA-1273-P201SSmRNA-1273-P201-US205-1049US2051049ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US205-1049US2051049A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US205-1049US2051049A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US205-1049US2051049A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B;mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B;mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÁmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÁmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÁmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÁmRNA-1273-P201SSmRNA-1273-P201-US205-1050US2051050B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US205-1051US2051051ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US205-1051US2051051A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US205-1052US2051052ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US205-1052US2051052A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US205-1053US2051053ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US205-1053US2051053A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÒmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÒmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeA°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-24B¶mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-24B¶mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054B COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-24B¶mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BXmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1054US2051054B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-24B¶mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30B#mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30B#mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1055US2051055B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1056US2051056ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US205-1056US2051056A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12.mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-31B$mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1057US2051057B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1058US2051058ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US205-1058US2051058A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US205-1058US2051058A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US205-1058US2051058A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US205-1059US2051059B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16Á mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060ACOVID Exposed to COVID-19 Y Y AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16Á mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCOVIDSYMParticipant COVID-19 Symptomatic N N AÐ(õÂ\(Safety Call Day 197 Unscheduled 1 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-13BnmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-13BnmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-13BnmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060B#COVID Exposed to COVID-19 SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-13BnmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1060US2051060B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1061US2051061ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US205-1061US2051061A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US205-1061US2051061A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US205-1061US2051061A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US205-1062US2051062ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US205-1062US2051062A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16ÁàmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-12-10B¤mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BËmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063A°COVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-18BËmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16ÁàmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-12-10B¤mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BËmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-18BËmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16BªmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-29B·mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16BªmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-29B·mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16BªmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-29B·mRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16BªmRNA-1273-P201SSmRNA-1273-P201-US205-1063US2051063B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-29B·mRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁàmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13AÐmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B:mRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÆmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁàmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13AÐmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B:mRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÆmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BVmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17BªmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-30B·mRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BVmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17BªmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-30B·mRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BVmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17BªmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-30B·mRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BVmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17BªmRNA-1273-P201SSmRNA-1273-P201-US205-1064US2051064B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-30B·mRNA-1273-P201SSmRNA-1273-P201-US205-1065US2051065ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US205-1065US2051065A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US205-1065US2051065A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US205-1065US2051065A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁÀmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AÀmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B(mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B6mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁÀmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AÀmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B(mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B6mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28B·mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28B·mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28B·mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BRmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BŠmRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1066US2051066B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28B·mRNA-1273-P201SSmRNA-1273-P201-US205-1067US2051067ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US205-1067US2051067A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁÐmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068ACOVID Exposed to COVID-19 N N Ap(õÂ$Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁÐmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-23ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCOVIDSYMParticipant COVID-19 Symptomatic N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-30B¸mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-30B¸mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-30B¸mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1068US2051068B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-30B¸mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-07AÀmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B>mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-27BØmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-07AÀmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B>mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-27BØmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-13BnmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-13BnmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-13BnmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-15BRmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-13BnmRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-08B¦mRNA-1273-P201SSmRNA-1273-P201-US205-1069US2051069B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18ÁÐmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AÐmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B"mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B)mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B;mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÍmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18ÁÐmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AÐmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B"mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B)mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B;mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÍmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31B¸mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31B¸mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31B¸mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US205-1070US2051070B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31B¸mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31BºmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31BºmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31BºmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US205-1071US2051071B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31BºmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19ÂmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072ACOVID Exposed to COVID-19 Y Y Ap(õÂ$Visit 6 Day 43 Unscheduled 1 PART A FOLLOW-UP 2020-09-21BNmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072A COVID Exposed to COVID-19 Y Y A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-21BNmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19ÂmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-25Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCOVIDSYMParticipant COVID-19 Symptomatic N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 PART A FOLLOW-UP 2020-09-21BNmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-21BNmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31B³mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31B³mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31B³mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1072US2051072B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31B³mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19ÂmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-05BmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B&mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B-mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÇmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19ÂmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-05BmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B&mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B-mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÇmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31B³mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31B³mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31B³mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1073US2051073B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-31B³mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÌmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÌmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-04B½mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-04B½mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-04B½mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1074US2051074B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-04B½mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AàmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B,mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B;mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AàmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B,mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B;mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BTmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BpmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-29B·mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BTmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BpmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-29B·mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BTmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BpmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-29B·mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BTmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BpmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1075US2051075B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-29B·mRNA-1273-P201SSmRNA-1273-P201-US205-1076US2051076ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US205-1076US2051076A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1077US2051077B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B,mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B8mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B,mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B8mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-04B½mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-04B½mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-04B½mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1078US2051078B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-04B½mRNA-1273-P201SSmRNA-1273-P201-US205-1079US2051079ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US205-1079US2051079A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US205-1080US2051080ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US205-1080US2051080A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US205-1080US2051080A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US205-1080US2051080A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÏmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÏmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BrmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US205-1081US2051081B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1082US2051082ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US205-1082US2051082A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US205-1082US2051082A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US205-1082US2051082A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US205-1083US2051083ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US205-1083US2051083A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US205-1083US2051083A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US205-1083US2051083A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10A mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B+mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B@mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÍmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10A mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B+mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B@mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÍmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US205-1084US2051084B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B>mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B>mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B½mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B½mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B½mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1085US2051085B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B½mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24ÁÀmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B<mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24ÁÀmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B<mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B¹mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B¹mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B¹mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1086US2051086B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06B¹mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B&mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BAmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B&mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BAmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÈmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BºmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BºmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BºmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1087US2051087B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BºmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US205-1088US2051088B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AàmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AàmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1089US2051089B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-07B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1090US2051090ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US205-1090US2051090A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US205-1091US2051091ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US205-1091US2051091A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US205-1091US2051091A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US205-1091US2051091A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-26Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-01Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-15AmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21AðmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-06BmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B&mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B+mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B;mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092A COVID Exposed to COVID-19 Y Y A°(õÂ$Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-12-08B›mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BËmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-26Á°mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-07-01Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-15AmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21AðmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-06BmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B&mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B+mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B;mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-12-08B›mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BËmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BUmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BqmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B½mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BUmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BqmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B½mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BUmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BqmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B½mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BUmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BqmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1092US2051092B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B½mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-26Á mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B.mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B:mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093A COVID Exposed to COVID-19 Y Y A(õÂ$Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-01BXmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093A°COVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-11-09BmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093AÀCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÇmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-26Á mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093AàCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093AðCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B.mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B:mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-01BXmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-11-09BmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÇmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B«mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B!CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B«mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B"CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B«mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B«mRNA-1273-P201SSmRNA-1273-P201-US205-1093US2051093B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-02ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-16A mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B$mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B+mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B:mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÇmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29Á€mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-02ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-16A mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B$mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B+mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B:mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÇmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BUmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BqmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B½mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BUmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BqmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B½mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BUmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BqmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B½mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BUmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-27BqmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BmRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US205-1094US2051094B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B½mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29Á0mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B*mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B8mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29Á0mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B*mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B8mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÄmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1095US2051095B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-02Á@mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-02Á@mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1096US2051096B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1097US2051097B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-05BmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B&mRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BAmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÇmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-05BmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B&mRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BAmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÇmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1098US2051098B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11B¾mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B;mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÌmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B;mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÌmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1099US2051099B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29Á0mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AàmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04B"mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B)mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B0mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BEmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÊmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29Á0mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AàmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04B"mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B)mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B0mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BEmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÊmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23B‘mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23B‘mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23B‘mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23B‘mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1100US2051100B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÂmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-15A mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-26B4mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-10BCmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-27BÎmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-15A mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-26B4mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-10BCmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-27BÎmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BVmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-30B”mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B«mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BVmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-30B”mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B«mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BVmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-30B”mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B«mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BVmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-30B”mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B«mRNA-1273-P201SSmRNA-1273-P201-US205-1101US2051101B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÌmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÌmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1102US2051102B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30Á mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B9mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30Á mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16AðmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B9mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1103US2051103B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1104US2051104ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1104US2051104A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US205-1104US2051104A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-17A°mRNA-1273-P201SSmRNA-1273-P201-US205-1104US2051104A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AàmRNA-1273-P201SSmRNA-1273-P201-US205-1104US2051104APCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30ÁpmRNA-1273-P201SSmRNA-1273-P201-US205-1104US2051104A`COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US205-1104US2051104ApCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-17A°mRNA-1273-P201SSmRNA-1273-P201-US205-1104US2051104A€COVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AàmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30Á mRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AàmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B9mRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105ACOVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-30B[mRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105A COVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-12-04BœmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30Á mRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AàmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B%mRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B9mRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-30B[mRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-12-04BœmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18BªmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18BªmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105B!COVID Exposed to COVID-19 SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18BªmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BrmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18BªmRNA-1273-P201SSmRNA-1273-P201-US205-1105US2051105B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B:mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-02-02BÔmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B:mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-02-02BÔmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1106US2051106B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30Á mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107A COVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-27BÒmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30Á mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-27BÒmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BVmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US205-1107US2051107B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÃmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-25B3mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BAmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-11-11BmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÍmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-25B3mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BAmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-11-11BmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÍmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1108US2051108B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B&mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B-mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B;mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÆmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B&mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B-mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B;mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÆmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BVmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BVmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BVmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-29BVmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1109US2051109B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12B¿mRNA-1273-P201SSmRNA-1273-P201-US205-1110US2051110ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US205-1110US2051110A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-24B2mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÌmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-24B2mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÌmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1111US2051111B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01ÁPmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20AðmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03BmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÉmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÀmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US205-1112US2051112B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÀmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B6mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B>mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04B×mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B6mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B>mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04B×mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BSmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BSmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BSmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BSmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1001US2061001B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US206-1002US2061002ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US206-1002US2061002A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US206-1002US2061002A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US206-1002US2061002A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B!mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B(mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B/mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B=mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B!mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B(mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B/mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B=mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BSmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BSmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BSmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BSmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1003US2061003B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US206-1004US2061004ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US206-1004US2061004A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US206-1004US2061004A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US206-1004US2061004A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US206-1005US2061005ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US206-1005US2061005A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÆmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÆmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1006US2061006B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1007US2061007ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US206-1007US2061007A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AàmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B)mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B0mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÆmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AàmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B)mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B0mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÆmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-14BâmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-14BâmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-14BâmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-14BâmRNA-1273-P201SSmRNA-1273-P201-US206-1008US2061008B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B?mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009ACOVID Exposed to COVID-19 N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-07BmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B?mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-07BmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1009US2061009B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B?mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B?mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1010US2061010B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B)mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BEmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÛmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B)mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BEmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-25BsmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÛmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1011US2061011B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1012US2061012ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US206-1012US2061012A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US206-1012US2061012A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US206-1012US2061012A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á€mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÀmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B'mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B=mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013A°COVID Exposed to COVID-19 Y Y Aà(õÂ$Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-29BÐmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á€mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÀmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B'mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B=mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-29BÐmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1013US2061013B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1014US2061014ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US206-1014US2061014A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US206-1014US2061014A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US206-1014US2061014A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015A@COVID Exposed to COVID-19 N N A0(õÂ\(Visit 2 Day 8 Unscheduled 1 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B3mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B@mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BËmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0(õÂ\(Visit 2 Day 8 Unscheduled 1 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B3mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B@mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BËmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1015US2061015B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1016US2061016ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US206-1016US2061016A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US206-1016US2061016A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US206-1016US2061016A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US206-1017US2061017ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US206-1017US2061017A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B1mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BEmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-01B´mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÑmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018A°COVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-30BÑmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B1mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BEmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-01B´mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÑmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-30BÑmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1018US2061018B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B0mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019ACOVID Exposed to COVID-19 N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B0mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-29B9mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1019US2061019B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÔmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÔmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BumRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B«mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BumRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B«mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BumRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B«mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-02BumRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B«mRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1020US2061020B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B9mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B%mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-30B9mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BomRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1021US2061021B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AàmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B&mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B8mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BËmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AàmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B&mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B8mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BËmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1022US2061022B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023A0COVID Exposed to COVID-19 N N A (õÂ\(Visit 1 Day 1 Unscheduled 1 BLINDED TREATMENT 2020-06-11ApmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AÐmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B'mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023A COVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-07B}mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023AàCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Visit 1 Day 1 Unscheduled 1 BLINDED TREATMENT 2020-06-11ApmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AÐmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B'mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-07B}mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023B CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1023US2061023B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B&mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B?mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024ACOVID Exposed to COVID-19 N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-30BµmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B&mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B?mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-30BµmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BãmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BãmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BãmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BãmRNA-1273-P201SSmRNA-1273-P201-US206-1024US2061024B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B&mRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B;mRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BËmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁPmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B&mRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B;mRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BËmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BTmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1025US2061025B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B=mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026ACOVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-16BhmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B=mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-16BhmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BSmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¦mRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1026US2061026B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÀmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B?mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÀmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B?mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1027US2061027B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1028US2061028ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US206-1028US2061028A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US206-1028US2061028A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US206-1028US2061028A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US206-1029US2061029ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US206-1029US2061029A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US206-1029US2061029A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US206-1029US2061029A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US206-1030US2061030ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US206-1030US2061030A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B>mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÖmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B>mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÖmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BomRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1032US2061032B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US206-1033US2061033ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US206-1033US2061033A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US206-1033US2061033A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US206-1033US2061033A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US206-1034US2061034ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US206-1034US2061034A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US206-1034US2061034A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US206-1034US2061034A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-08.mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035A COVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-04BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18B6mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-04BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US206-1035US2061035B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036ACOVID Exposed to COVID-19 N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-14BŽmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-14BŽmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-14BŽmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-16BSmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-14BomRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-14BŽmRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US206-1036US2061036B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B0mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B>mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B0mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B>mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BºmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BVmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BVmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BVmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BVmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-11B‹mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¬mRNA-1273-P201SSmRNA-1273-P201-US206-1037US2061037B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1038US2061038ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US206-1038US2061038A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US206-1038US2061038A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-09.mRNA-1273-P201SSmRNA-1273-P201-US206-1038US2061038A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US206-1039US2061039ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US206-1039US2061039A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US206-1040US2061040ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US206-1040US2061040A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US206-1040US2061040A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US206-1040US2061040A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US206-1041US2061041ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US206-1041US2061041A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US206-1041US2061041A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US206-1041US2061041A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US206-1042US2061042ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US206-1042US2061042A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US206-1042US2061042A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US206-1042US2061042A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B&mRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B6mRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B&mRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B6mRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BSmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BSmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BSmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BSmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US206-1043US2061043B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1044US2061044ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US206-1044US2061044A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US206-1044US2061044A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10.mRNA-1273-P201SSmRNA-1273-P201-US206-1044US2061044A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-20B5mRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-10ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B,mRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-20B5mRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BSmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BSmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BSmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BSmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US206-1045US2061045B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A°mRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046A COVID Exposed to COVID-19 Y Y AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046A°COVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-15BÉmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A°mRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27BmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-15BªmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-15BÉmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BSmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BSmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BSmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046B$COVID Exposed to COVID-19 SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-19BSmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BnmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŽmRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US206-1046US2061046B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US206-1047US2061047ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US206-1047US2061047A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US206-1047US2061047A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US206-1047US2061047A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US206-1048US2061048ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US206-1048US2061048A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US206-1048US2061048A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US206-1048US2061048A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US206-1049US2061049ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US206-1049US2061049A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US206-1049US2061049A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US206-1049US2061049A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US206-1050US2061050ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US206-1050US2061050A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US206-1050US2061050A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US206-1050US2061050A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15ÁðmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AàmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B&mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B8mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05B¾mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15ÁðmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AàmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30BmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B&mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B8mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05B¾mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BXmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BrmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BXmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BrmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BXmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BrmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BXmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BrmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1051US2061051B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1052US2061052ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US206-1052US2061052A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US206-1052US2061052A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US206-1052US2061052A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AÐmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B7mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÎmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15ÂmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AÐmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B7mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÎmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BSmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US206-1053US2061053B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1054US2061054ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US206-1054US2061054A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US206-1054US2061054A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US206-1054US2061054A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16ÁàmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B8mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16ÁàmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B8mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BWmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BWmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BWmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BWmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BŒmRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1055US2061055B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1056US2061056ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US206-1056US2061056A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US206-1056US2061056A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US206-1056US2061056A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18ÁÐmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23Á€mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10A mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B+mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B7mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18ÁÐmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23Á€mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10A mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B+mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B7mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÃmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US206-1057US2061057B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1058US2061058ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US206-1058US2061058A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US206-1059US2061059ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US206-1059US2061059A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US206-1059US2061059A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US206-1059US2061059A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US206-1060US2061060ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US206-1060US2061060A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US206-1060US2061060A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US206-1060US2061060A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US206-1061US2061061ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US206-1061US2061061A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US206-1061US2061061A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US206-1061US2061061A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US206-1062US2061062ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US206-1062US2061062A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US206-1062US2061062A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US206-1062US2061062A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22Á€mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-24Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AàmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 .mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B?mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22Á€mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-24Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AàmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B$mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 .mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B?mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BXmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BXmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BXmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BXmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US206-1063US2061063B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22Á€mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B8mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÆmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22Á€mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AðmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B8mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÆmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BWmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BWmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BWmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BWmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1064US2061064B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1065US2061065ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US206-1065US2061065A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US206-1065US2061065A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US206-1065US2061065A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US206-1066US2061066ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US206-1066US2061066A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US206-1067US2061067ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US206-1067US2061067A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US206-1067US2061067A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US206-1067US2061067A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26Á@mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 .mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02BAmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BËmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24Á`mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26Á@mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07A€mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31B mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 .mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02BAmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BËmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BWmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BWmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BWmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BWmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B¨mRNA-1273-P201SSmRNA-1273-P201-US206-1068US2061068B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÁmRNA-1273-P201SSmRNA-1273-P201-US206-1069US2061069ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US206-1069US2061069A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US206-1070US2061070ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US206-1070US2061070A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-02.mRNA-1273-P201SSmRNA-1273-P201-US206-1070US2061070A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-29.mRNA-1273-P201SSmRNA-1273-P201-US206-1070US2061070A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-02.mRNA-1273-P201SSmRNA-1273-P201-US206-1071US2061071ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US206-1071US2061071A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US206-1072US2061072ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US206-1072US2061072A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US206-1072US2061072A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01.mRNA-1273-P201SSmRNA-1273-P201-US206-1072US2061072A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-06.mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-22ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-10AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30B!mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B+mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B2mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-28B™mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÖmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001A°COVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-04BÝmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-22ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-05A€mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-10AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30B!mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B+mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B2mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-28B™mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÖmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-04BÝmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28B\mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-16BomRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-19BìmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28B\mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-16BomRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001B CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-19BìmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28B\mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-16BomRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-19BìmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28B\mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-16BomRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-15BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-11B§mRNA-1273-P201SSmRNA-1273-P201-US207-1001US2071001B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-19BìmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-22Á mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002ApCOVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B.mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-22Á mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-12AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B.mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US207-1002US2071002B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-22Á mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B(mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003ACOVID Exposed to COVID-19 N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-30B·mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-22Á mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B(mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-30B·mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÓmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-18BnmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US207-1003US2071003B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BëmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25Á mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AàmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B#mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B1mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B@mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004ACOVID Exposed to COVID-19 N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-14B…mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004A COVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-12B¢mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÑmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25Á mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AàmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B#mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B1mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B@mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-14B…mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-12B¢mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÑmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004B CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1004US2071004B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B1mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B<mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005ACOVID Exposed to COVID-19 N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-25B±mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005A COVID Exposed to COVID-19 Y Y AÀQë…¸PSafety Call Day 169 Unscheduled 2 PART A FOLLOW-UP 2020-12-28BÒmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÝmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B1mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B<mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-25B±mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀQë…¸PSafety Call Day 169 Unscheduled 2 PART A FOLLOW-UP 2020-12-28BÒmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÝmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B\mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B\mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B\mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B\mRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1005US2071005B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÒmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B8mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÒmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1006US2071006B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BBmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-03B›mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BàmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BBmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-03B›mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BàmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31B[mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31B[mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31B[mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31B[mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1007US2071007B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US207-1008US2071008ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1008US2071008A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1009US2071009ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1009US2071009A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1010US2071010ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1010US2071010A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1011US2071011ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1011US2071011A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25ÁmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B@mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-04B¹mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BËmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012A°COVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-04BØmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25ÁmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B@mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-04B¹mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BËmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-04BØmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B]mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B]mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012B CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B]mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B]mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1012US2071012B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B4mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B?mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÒmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B4mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B?mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÒmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B^mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B^mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B^mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013B#COVID Exposed to COVID-19 SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B^mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1013US2071013B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25ÁmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B?mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÙmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25ÁmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B?mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÙmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BZmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BZmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BZmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BZmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1014US2071014B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1015US2071015ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1015US2071015A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25ÁmRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B0mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25ÁmRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B,mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B0mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B]mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B]mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B]mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B]mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1016US2071016B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017A€COVID Exposed to COVID-19 Y Y A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18BNmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-11B£mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BËmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-18BNmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-11B£mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BËmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BrmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US207-1017US2071017B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US207-1018US2071018ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1018US2071018A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1019US2071019ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1019US2071019A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1020US2071020ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1020US2071020A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1021US2071021ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1021US2071021A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-25.mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B&mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BAmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022ACOVID Exposed to COVID-19 N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÛmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B&mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B-mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BAmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÛmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022B#COVID Exposed to COVID-19 SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1022US2071022B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US207-1023US2071023ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US207-1023US2071023A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1024US2071024B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B@mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÌmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11AmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B$mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B+mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B2mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B@mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÌmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B]mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B]mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B]mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B]mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1025US2071025B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26ÁÐmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-30B5mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BBmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÔmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26ÁÐmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026A°COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-30B5mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BBmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÔmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-08B]mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-08B]mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-08B]mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-08B]mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1026US2071026B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1027US2071027ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US207-1027US2071027A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US207-1028US2071028ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US207-1028US2071028A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B$mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B+mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B5mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B>mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029A°COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B$mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B+mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B5mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B>mRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BYmRNA-1273-P201SSmRNA-1273-P201-US207-1029US2071029BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BYmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B3mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BFmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B3mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BFmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BWmRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1030US2071030B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁÀmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B!mRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BBmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÞmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁÀmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B!mRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-12BBmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÞmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B!CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1032US2071032B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁÀmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-13BCmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÖmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁÀmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-13BCmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÖmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1033US2071033B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1034US2071034ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US207-1034US2071034A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US207-1035US2071035ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US207-1035US2071035A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁÀmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-29B4mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BAmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÎmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁÀmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-29B4mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BAmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÎmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-08B]mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-08B]mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B!CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-08B]mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-08B]mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1036US2071036B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B4mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B4mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BZmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BZmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BZmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BZmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BpmRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B§mRNA-1273-P201SSmRNA-1273-P201-US207-1037US2071037B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B(mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B/mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-29B8mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BEmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-01BµmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÒmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B(mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B/mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-29B8mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BEmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-01BµmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÒmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-04B]mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-04B]mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-04B]mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-04B]mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US207-1038US2071038B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BïmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B'mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-30B8mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-13BFmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-13BFmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BàmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A°mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B'mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-30B8mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-13BFmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-13BFmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BàmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-08B`mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-08B`mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-08B`mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-08B`mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1039US2071039B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-28B3mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÍmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-01ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-28B3mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÍmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09B^mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09B^mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09B^mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-09B^mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1040US2071040B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B'mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-09B‚mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041A COVID Exposed to COVID-19 N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-06BžmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÒmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02BmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-10B'mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B.mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-09B‚mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-06BžmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÒmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BXmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1041US2071041B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B2mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07BAmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B2mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07BAmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BrmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1042US2071042B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BìmRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B)mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B0mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B"mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B)mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B0mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B>mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B[mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B[mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B[mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01B[mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BomRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1043US2071043B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BîmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÖmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÖmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1044US2071044B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1045US2071045ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US207-1045US2071045A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BEmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÒmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BEmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-30BÒmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1046US2071046B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1048US2071048ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US207-1048US2071048A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B#mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B@mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B#mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B@mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BYmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1049US2071049B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AàmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B@mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÉmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050A°COVID Exposed to COVID-19 N N Aà(õÂ$Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-04BÖmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AàmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B@mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÉmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-04BÖmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050B CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1050US2071050B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051ApCOVID Exposed to COVID-19 Y Y A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051A COVID Exposed to COVID-19 Y Y AÀ(õÂ$Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-11B¾mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051AÀCOVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-30BÑmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051AÐCOVID Exposed to COVID-19 Y Y AàQë…¸PVisit 8 Day 209 Unscheduled 2 PART A FOLLOW-UP 2021-01-13BßmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051AàCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051AðCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B<mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-11B¾mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-30BÑmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCOVIDSYMParticipant COVID-19 Symptomatic N N AàQë…¸PVisit 8 Day 209 Unscheduled 2 PART A FOLLOW-UP 2021-01-13BßmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B CONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B!CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B"CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B#CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B$CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B%CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B&COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B'COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B(COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B)COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B*COVID Exposed to COVID-19 SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1051US2071051B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1053US2071053ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US207-1054US2071054ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US207-1054US2071054A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US207-1055US2071055ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US207-1055US2071055A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US207-1056US2071056ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US207-1056US2071056A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US207-1058US2071058ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US207-1058US2071058A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÞmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÞmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1059US2071059B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1060US2071060ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US207-1060US2071060A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US207-1061US2071061ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US207-1061US2071061A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B>mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062ACOVID Exposed to COVID-19 N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BßmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B>mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BßmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BZmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BZmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BZmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062B#COVID Exposed to COVID-19 SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BZmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1062US2071062B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AàmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B3mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B@mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BàmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AàmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B,mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B3mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B@mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BàmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B[mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B[mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B[mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02B[mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BpmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B§mRNA-1273-P201SSmRNA-1273-P201-US207-1063US2071063B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B#mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B*mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B@mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BámRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B#mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B*mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B@mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BámRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BçmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BçmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064BCOVID Exposed to COVID-19 SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BçmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BXmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1064US2071064B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BçmRNA-1273-P201SSmRNA-1273-P201-US207-1065US2071065ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US207-1065US2071065A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17AmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AàmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B&mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B*mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B8mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÄmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17AmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AàmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B&mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B*mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B8mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÄmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BWmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BpmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BWmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BpmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BWmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BpmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BWmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BpmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1066US2071066B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B+mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B0mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-13BFmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B+mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B0mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-13BFmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1067US2071067B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068A COVID Exposed to COVID-19 Y Y A°(õÂ$Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-10BœmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-10BœmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCONSTAT Contact Status SAFETY CALLContact Not MadeContact Not MadeASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BtmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BtmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068B CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BtmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068B%COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-01BtmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1068US2071068B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-28B3mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-17BGmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÛmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-28B3mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-17BGmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÛmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-04BYmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-04BYmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-04BYmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-04BYmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-29BmRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1069US2071069B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070ACOVID Exposed to COVID-19 N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÛmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÛmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BWmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1070US2071070B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B1mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BDmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÞmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B!mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B1mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BDmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÞmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BtmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BtmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BtmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03B[mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BtmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1071US2071071B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BëmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B'mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B9mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072A COVID Exposed to COVID-19 Y Y AÀQë…¸PSafety Call Day 169 Unscheduled 2 PART A FOLLOW-UP 2020-12-04B·mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072AÀCOVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-04BÖmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B'mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B.mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-31B9mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀQë…¸PSafety Call Day 169 Unscheduled 2 PART A FOLLOW-UP 2020-12-04B·mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-04BÖmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B!CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B"CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B#CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B$COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B%COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B&COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B'COVID Exposed to COVID-19 SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BpmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B§mRNA-1273-P201SSmRNA-1273-P201-US207-1072US2071072B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BìmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1073US2071073B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-09B¹mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÛmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-09B¹mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÛmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-04BYmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-04BYmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B!CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-04BYmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-04BYmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1074US2071074B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1075US2071075ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US207-1075US2071075A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US207-1076US2071076ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US207-1076US2071076A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077APCOVID Exposed to COVID-19 Y Y APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B!mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B.mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÞmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-10B!mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B.mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-04B:mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÞmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B!CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B%COVID Exposed to COVID-19 SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1077US2071077B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-25CpmRNA-1273-P201SSmRNA-1273-P201-US207-1078US2071078ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US207-1078US2071078A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US207-1079US2071079ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US207-1079US2071079A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US207-1080US2071080ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US207-1080US2071080A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05.mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÝmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07BmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÝmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081B"COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US207-1081US2071081B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BëmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B>mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B>mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1082US2071082B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071057ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-26ÂmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083ACOVID Exposed to COVID-19 N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÁmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071057AÀCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-26ÂmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCOVIDSYMParticipant COVID-19 Symptomatic N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÁmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1083US2071083B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B0mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B0mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BtmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1084US2071084B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1085US2071085B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086A0COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086A@COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086APCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B0mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086A`COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086ApCOVID Exposed to COVID-19 N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086A€COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÉmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086A°COVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086AÐCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B0mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086AàCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086AðCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-11-10BŠmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÉmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1086US2071086B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30B#mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B2mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087A€COVID Exposed to COVID-19 Y Y A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B@mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-02BEmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087A COVID Exposed to COVID-19 Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-29B`mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-30B#mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B2mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B@mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-02BEmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-29B`mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1087US2071087B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071052ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-29ÂmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-08AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B0mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071052A°COVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-29ÂmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-08AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B0mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÊmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1088US2071088B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071031ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-26ÂmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B1mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B?mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089A COVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-20BumRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071031AÀCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-26ÂmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B1mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B?mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-20BumRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1089US2071089B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B(mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-01BAmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÆmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B(mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-01BAmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÆmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1090US2071090B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091A COVID Exposed to COVID-19 N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-20BumRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091A°COVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-22B´mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091AÀCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÉmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AðmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-27B mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B(mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-07B+mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-10-20BumRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-22B´mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÉmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091B!CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1091US2071091B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-08AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-19B7mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092ACOVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092A COVID Exposed to COVID-19 N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-16B®mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÉmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-08AÐmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-28B!mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-05B)mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-19B7mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-16B®mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-12BÉmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-17BTmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-15BpmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-12BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1092US2071092B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-09B§mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B(mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01BAmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÌmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B(mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B-mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01BAmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÌmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1093US2071093B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22ÁàmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094A COVID Exposed to COVID-19 N N A€(õÂ$Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-04B=mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094A°COVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2021-01-04B·mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094AÀCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22ÁàmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094AàCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-25Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094AðCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B9mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-04B=mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2021-01-04B·mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BWmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BWmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094B!CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BWmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BWmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1094US2071094B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÓmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13AðmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B+mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B:mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2021-01-08BÂmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÓmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1095US2071095B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071047ACOVID Exposed to COVID-19 N N Previous Screening SCREENING 2020-05-28Â#mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096A COVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096A0COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-30Á mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096A@COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096APCOVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096A`COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096ApCOVID Exposed to COVID-19 N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096A€COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-05B#mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096ACOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096A COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-21B3mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096A°COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-04BAmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096AÀCOVID Exposed to COVID-19 N N A€(õÂ$Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-16BMmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096AÐCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071047AàCOVIDSYMParticipant COVID-19 Symptomatic N N Previous Screening SCREENING 2020-05-28Â#mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096AðCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24Á€mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-30Á mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCOVIDSYMParticipant COVID-19 Symptomatic N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-05B#mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-21B3mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-04BAmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-16BMmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BTmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BTmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096B CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096B!CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096B"CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096B#CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096B$COVID Exposed to COVID-19 SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BTmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096B%COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096B&COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096B'COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BTmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17B‹mRNA-1273-P201SSmRNA-1273-P201-US207-1096US2071096B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US207-1097US2071097ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US207-1097US2071097A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AðmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B,mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B2mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B>mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-11-10B…mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÌmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24ÁpmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15AðmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B,mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B2mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B>mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-11-10B…mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÌmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BTmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BomRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1098US2071098B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24ÁÐmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-15AmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21AðmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B$mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B*mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099ACOVID Exposed to COVID-19 N N Ap(õÂ$Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-26B3mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B;mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099A°COVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-10BBmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099AÀCOVID Exposed to COVID-19 Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-08B^mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099AÐCOVID Exposed to COVID-19 N N AQë…¸PSafety Call Day 85 Unscheduled 2 PART A FOLLOW-UP 2020-10-09B_mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099AàCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÅmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099AðCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24ÁÐmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-26Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-15AmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21AðmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B$mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B*mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-26B3mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B;mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-09-10BBmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-08B^mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N AQë…¸PSafety Call Day 85 Unscheduled 2 PART A FOLLOW-UP 2020-10-09B_mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÅmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BTmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BpmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B CONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B!CONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BTmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B"CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BpmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B#CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B$CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B%CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B&COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BTmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B'COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BpmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B(COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B)COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BTmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BpmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BŒmRNA-1273-P201SSmRNA-1273-P201-US207-1099US2071099B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¨mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B.mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100ACOVID Exposed to COVID-19 N N Ap(õÂ$Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-26B4mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B<mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25Á°mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-04BmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B.mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCOVIDSYMParticipant COVID-19 Symptomatic N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-08-26B4mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03B<mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1100US2071100B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1101US2071101ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1101US2071101A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US207-1101US2071101A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US207-1101US2071101A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1101US2071101APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US207-1101US2071101A`COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1101US2071101ApCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US207-1101US2071101A€COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US207-1101US2071101ACOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-10AÀmRNA-1273-P201SSmRNA-1273-P201-US207-1101US2071101A COVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B$mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A°mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÇmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25Á@mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A°mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14BmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-28BmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-04B%mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B9mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-13BÇmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US207-1102US2071102B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-26Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-21B3mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103A€COVID Exposed to COVID-19 Y Y A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-11BHmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103ACOVID Exposed to COVID-19 Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-09BdmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103A COVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2021-01-04B»mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÐmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-26Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-10AmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-21B3mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-11BHmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-09BdmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2021-01-04B»mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÐmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BTmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BTmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103B COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BTmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103B!COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103B"COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103B#COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BTmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BpmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US207-1103US2071103B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B§mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-26Á mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-19B-mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-26B4mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-04B=mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104ACOVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-29BVmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÌmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-26Á mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-19B-mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-26B4mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-04B=mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-29BVmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÌmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1104US2071104B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-19B-mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-26B4mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-09BBmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÌmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-30Á`mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-19B-mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-26B4mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-09BBmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-25BÌmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1105US2071105B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-07-01ÁPmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106A0COVID Exposed to COVID-19 Y Y A0Visit 2 Day 8 PART A FOLLOW-UP 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106A@COVID Exposed to COVID-19 N N A0(õÂ\(Visit 2 Day 8 Unscheduled 1 PART A FOLLOW-UP 2020-07-15A mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106APCOVID Exposed to COVID-19 N N A0Që…¸RVisit 2 Day 8 Unscheduled 2 PART A FOLLOW-UP 2020-08-13B'mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106A`COVID Exposed to COVID-19 N N A@Visit 3 Day 15 .mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106ApCOVID Exposed to COVID-19 N N APVisit 4 Day 29 .mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106A€COVID Exposed to COVID-19 N N A`Visit 5 Day 36 .mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 PART A FOLLOW-UP 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B4mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÆmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-07-01ÁPmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 PART A FOLLOW-UP 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0(õÂ\(Visit 2 Day 8 Unscheduled 1 PART A FOLLOW-UP 2020-07-15A mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Që…¸RVisit 2 Day 8 Unscheduled 2 PART A FOLLOW-UP 2020-08-13B'mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 .mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 .mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 .mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 PART A FOLLOW-UP 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B4mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÆmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BëmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106B CONTACT Contact Attempted SAFETY CALLN N AÐSafety Call Day 197 .mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106B!CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BëmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106B"COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106B#COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106B$COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106B%COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BëmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US207-1106US2071106B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BëmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-01B"mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-08B)mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-23B8mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-11BKmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001A°COVID Exposed to COVID-19 Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-02-03BûmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-01B"mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-08B)mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-23B8mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-11BKmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCOVIDSYMParticipant COVID-19 Symptomatic N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-02-03BûmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-20BTmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BîmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-20BTmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BîmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-20BTmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BîmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-20BTmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1001US2081001B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BîmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-25BmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-02B#mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-09B*mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-24B9mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-25BmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-02B#mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-09B*mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-24B9mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-08BÂmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BîmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BîmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BîmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1002US2081002B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BîmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B'mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-13B.mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BîmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BîmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BîmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-13B©mRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1003US2081003B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-21BîmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004A`COVID Exposed to COVID-19 Y Y AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-01B"mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B)mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B0mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-05-29AmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A°mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29B mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCOVIDSYMParticipant COVID-19 Symptomatic N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-01B"mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B)mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B0mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B<mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BïmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BïmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BïmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BtmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-14B‹mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1004US2081004B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BïmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B/mRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005A COVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-08BÞmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-17B/mRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-08BÞmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1005US2081005B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1006US2081006ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US208-1006US2081006A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-26.mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007A€COVID Exposed to COVID-19 Y Y Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-07-21B3mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCOVIDSYMParticipant COVID-19 Symptomatic N N Ap(õÂ\(Visit 6 Day 43 Unscheduled 1 BLINDED TREATMENT 2020-07-21B3mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BrmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1007US2081007B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1008US2081008ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US208-1008US2081008A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02B mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-02B mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B-mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1009US2081009B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1010US2081010ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US208-1010US2081010A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US208-1011US2081011ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US208-1011US2081011A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US208-1012US2081012ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US208-1012US2081012A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US208-1013US2081013ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US208-1013US2081013A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27.mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014A`COVID Exposed to COVID-19 N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B.mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCOVIDSYMParticipant COVID-19 Symptomatic N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B&mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B.mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014B#COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1014US2081014B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015ApCOVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-09B'mRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-27B9mRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-16BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BVmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1015US2081015B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-27ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08A€mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AðmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B$mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-14B,mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B:mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C€mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C€mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C€mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BYmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BìmRNA-1273-P201SSmRNA-1273-P201-US208-1016US2081016B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-19C€mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BBmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÚmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BBmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÚmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1017US2081017B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1018US2081018ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US208-1018US2081018A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÒmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-30BmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-08B%mRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÒmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1019US2081019B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020ACOVID Exposed to COVID-19 N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-06-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-15B,mRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-14BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1020US2081020B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-22BëmRNA-1273-P201SSmRNA-1273-P201-US208-1021US2081021ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US208-1021US2081021A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US208-1022US2081022ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US208-1022US2081022A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B0mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B@mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15AÐmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B0mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B@mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÊmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BVmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BVmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BVmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BVmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1023US2081023B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US208-1024US2081024ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US208-1024US2081024A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28.mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BAmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÑmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-28Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10A€mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17AðmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B#mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B*mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B1mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BAmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÑmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B'COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-26BUmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-21BmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-16BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BímRNA-1273-P201SSmRNA-1273-P201-US208-1025US2081025B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B@mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026A COVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-07BÚmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B0mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B@mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-07BÚmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1026US2081026B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US208-1027US2081027ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US208-1027US2081027A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BBmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BËmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BBmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BËmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1028US2081028B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BBmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÌmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BBmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÌmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-24BTmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1029US2081029B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B1mRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B?mRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÌmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-16AðmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-06B#mRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-13B*mRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B1mRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-03B?mRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÌmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US208-1030US2081030B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1031US2081031ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US208-1031US2081031A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US208-1032US2081032ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US208-1032US2081032A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033APCOVID Exposed to COVID-19 N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BBmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÌmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033A°COVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-05BÚmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCOVIDSYMParticipant COVID-19 Symptomatic N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B$mRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B+mRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B2mRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06BBmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-22BÌmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-05BÚmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-18BªmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1033US2081033B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1034US2081034ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US208-1034US2081034A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-13BImRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-15AàmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-01BmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-09B&mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-16B-mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-07-28B9mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-13BImRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1035US2081035B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BïmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036A0COVID Exposed to COVID-19 N N A (õÂ\(Visit 1 Day 1 Unscheduled 1 BLINDED TREATMENT 2020-06-06A0mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B2mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B@mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036A COVID Exposed to COVID-19 N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-20BªmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036A°COVID Exposed to COVID-19 N N AÀQë…¸PSafety Call Day 169 Unscheduled 2 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036AÀCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BâmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036AðCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Visit 1 Day 1 Unscheduled 1 BLINDED TREATMENT 2020-06-06A0mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B$mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B+mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B2mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B@mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-11-20BªmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AÀQë…¸PSafety Call Day 169 Unscheduled 2 PART A FOLLOW-UP 2020-12-15BÃmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BâmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B!CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B"CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B#CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B$CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B)COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B*COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1036US2081036B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-26BímRNA-1273-P201SSmRNA-1273-P201-US208-1037US2081037ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US208-1037US2081037A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-05-29.mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1038US2081038B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039A`COVID Exposed to COVID-19 Y Y A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039ApCOVID Exposed to COVID-19 Y Y A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B.mRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039A COVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-04BYmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÓmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B.mRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-04BYmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-04BÓmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-23BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-23BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B#COVID Exposed to COVID-19 SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-23BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-23BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1039US2081039B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1040US2081040ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US208-1040US2081040A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B*mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B/mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BEmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041A COVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12AmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B*mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B/mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-11BEmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCOVIDSYMParticipant COVID-19 Symptomatic Y Y AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCOVIDSYMParticipant COVID-19 Symptomatic Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2020-12-21BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BîmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BîmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BîmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1041US2081041B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BîmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01ÁmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A€mRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24AðmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B%mRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B,mRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B:mRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÛmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01ÁmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-10AmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-17A€mRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24AðmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B%mRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B,mRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B:mRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BÛmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BUmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BqmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B©mRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-02BîmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BUmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BqmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B©mRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-02BîmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BUmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BqmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B©mRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-02BîmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-02BUmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-30BqmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-28BmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-25B©mRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1042US2081042B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-02BîmRNA-1273-P201SSmRNA-1273-P201-US208-1043US2081043ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US208-1043US2081043A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US208-1044US2081044ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US208-1044US2081044A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01.mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045APCOVID Exposed to COVID-19 N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-25BmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B/mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07BAmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045A COVID Exposed to COVID-19 Y Y AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÚmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-01Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-04AmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-11A€mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-18AðmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-06-25BmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-07B"mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B)mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-20B/mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07BAmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-07BÚmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BîmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BîmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BîmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-27BUmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-24BqmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-19B©mRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-17BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1045US2081045B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-27BîmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B=mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046ACOVID Exposed to COVID-19 N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-30BsmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046A COVID Exposed to COVID-19 N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-30B‘mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08B×mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046AÀCOVID Exposed to COVID-19 Y Y Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-25BèmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-24B/mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B=mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-09-30BsmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-30B‘mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08B×mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-25BèmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B CONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B!CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B"CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B#CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B$CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B)COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B*COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1046US2081046B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1047US2081047ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US208-1047US2081047A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US208-1048US2081048ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US208-1048US2081048A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16A€mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23AðmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B&mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B-mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B;mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÓmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16A€mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23AðmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B&mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B-mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B;mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÓmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BUmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BqmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B©mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BUmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BqmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B©mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BUmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BqmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B©mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BUmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BqmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BmRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-24B©mRNA-1273-P201SSmRNA-1273-P201-US208-1049US2081049B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1050US2081050ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US208-1050US2081050A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02.mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BCmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BØmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-14B(mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10BCmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BØmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B©mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BïmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B©mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BïmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B©mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BïmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B©mRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1051US2081051B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BïmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B#mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B+mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B0mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B?mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052ACOVID Exposed to COVID-19 N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-27B‘mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÚmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052A°COVID Exposed to COVID-19 N N B\(õÃSafety Call Day 265 Unscheduled 1 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-02Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B#mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B+mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B0mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B?mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCOVIDSYMParticipant COVID-19 Symptomatic Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-10-27B‘mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-08BÚmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCOVIDSYMParticipant COVID-19 Symptomatic N N B\(õÃSafety Call Day 265 Unscheduled 1 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BïmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCONSTAT Contact Status SAFETY CALLContact Made Contact Made BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B!CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B"CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B#CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BïmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B$CONTACT Contact Attempted SAFETY CALLY Y BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B%COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B&COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B'COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B(COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B)COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B*COVID Exposed to COVID-19 SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BïmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B+COVID Exposed to COVID-19 SAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B/COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B0COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B1COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BïmRNA-1273-P201SSmRNA-1273-P201-US208-1052US2081052B2COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N BSafety Call Day 265 PART A FOLLOW-UP 2021-02-22CpmRNA-1273-P201SSmRNA-1273-P201-US208-1053US2081053ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US208-1053US2081053A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B>mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÏmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08B"mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B)mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-21B/mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B>mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-28BÏmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B©mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BîmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B©mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BîmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B©mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BîmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-20B©mRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1054US2081054B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BîmRNA-1273-P201SSmRNA-1273-P201-US208-1055US2081055ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US208-1055US2081055A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US208-1056US2081056ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US208-1056US2081056A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03.mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B#mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B+mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B1mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B>mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÐmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-03Á mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-05AmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-12A€mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-19AðmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B#mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B+mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B1mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-05B>mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-29BÐmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BîmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BîmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BîmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-25BqmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1057US2081057B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-28BîmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 PART A FOLLOW-UP 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 PART A FOLLOW-UP 2020-07-06BmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 PART A FOLLOW-UP 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 PART A FOLLOW-UP 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 PART A FOLLOW-UP 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 PART A FOLLOW-UP 2020-07-06BmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 PART A FOLLOW-UP 2020-07-14B%mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 PART A FOLLOW-UP 2020-07-21B,mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-03BXmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1058US2081058B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B2mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059ACOVID Exposed to COVID-19 N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BámRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-16AmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-13B$mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-20B+mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-27B2mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCOVIDSYMParticipant COVID-19 Symptomatic N N A€(õÂ\(Visit 7 Day 57 Unscheduled 1 PART A FOLLOW-UP 2020-08-10B@mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BámRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-01BVmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-29BrmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-27BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1059US2081059B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1060US2081060ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US208-1060US2081060A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US208-1061US2081061ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US208-1061US2081061A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-04.mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÔmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-17B(mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-05BÔmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1062US2081062B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063A`COVID Exposed to COVID-19 Y Y A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063ApCOVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÚmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-22AðmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-08BmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-07-15B&mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-22B-mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-06B<mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÚmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B&COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-22BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1063US2081063B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064A`COVID Exposed to COVID-19 N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-10B!mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B.mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B=mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064A°COVID Exposed to COVID-19 Y Y Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-02-15BýmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-05Á0mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-06-15A€mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-06-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-09B mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCOVIDSYMParticipant COVID-19 Symptomatic N N AP(õÂ\(Visit 4 Day 29 Unscheduled 1 BLINDED TREATMENT 2020-07-10B!mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-07-16B'mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-07-23B.mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-07B=mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-23BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCOVIDSYMParticipant COVID-19 Symptomatic N N Að(õÂ\(Safety Call Day 237 Unscheduled 1 PART A FOLLOW-UP 2021-02-15BýmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B!CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B'COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B(COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-08-31BUmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-09-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-10-26BmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-11-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B-COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2020-12-21BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1064US2081064B.COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-01-29BìmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÑmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1065US2081065B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-09AàmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-11B/mRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-25B=mRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1066US2081066B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1067US2081067ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US208-1067US2081067A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US208-1068US2081068ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US208-1068US2081068A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11.mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-24Á mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069A COVID Exposed to COVID-19 N N A(õÂ$Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-28B_mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-11ÁðmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-24Á mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069AàCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-24B<mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-28B_mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1069US2081069B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-06BÃmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÁàmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1070US2081070B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B,mRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B:mRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BËmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-12ÂmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B,mRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B:mRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BËmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1071US2081071B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1072US2081072B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073ACOVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-28B_mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 .mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15Á°mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-03A€mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-24BmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-03B'mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-10B.mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-21B9mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-28B_mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 .mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1073US2081073B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1074US2081074ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US208-1074US2081074A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15.mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-15ÁðmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B,mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B:mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075ACOVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-30B¸mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BËmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-15ÁðmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B%mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B,mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B:mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2020-12-30B¸mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BËmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1075US2081075B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16ÁðmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076A@COVID Exposed to COVID-19 N N A0(õÂ\(Visit 2 Day 8 Unscheduled 1 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B+mRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B3mRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03BAmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076A COVID Exposed to COVID-19 Y Y A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-27BÓmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16ÁðmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076AðCOVIDSYMParticipant COVID-19 Symptomatic N N A0(õÂ\(Visit 2 Day 8 Unscheduled 1 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-12B+mRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B3mRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-03BAmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-27BÓmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076B#COVID Exposed to COVID-19 SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1076US2081076B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16ÁàmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B#mRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B*mRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B2mRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B?mRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÌmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077A COVID Exposed to COVID-19 N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-22BÏmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16ÁàmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B#mRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B*mRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B2mRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B?mRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÌmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCOVIDSYMParticipant COVID-19 Symptomatic N N Aà(õÂ\(Visit 8 Day 209 Unscheduled 1 PART A FOLLOW-UP 2021-01-22BÏmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077B#COVID Exposed to COVID-19 SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1077US2081077B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1078US2081078ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US208-1078US2081078A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-16.mRNA-1273-P201SSmRNA-1273-P201-US208-1079US2081079ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US208-1079US2081079A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17.mRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁàmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B;mRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁàmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B;mRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1080US2081080B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-17ÁÀmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B<mRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-27BÕmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-17ÁÀmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A€mRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B'mRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B<mRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-27BÕmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US208-1081US2081081B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1082US2081082ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US208-1082US2081082A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US208-1083US2081083ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US208-1083US2081083A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US208-1083US2081083A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US208-1083US2081083A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-30.mRNA-1273-P201SSmRNA-1273-P201-US208-1084US2081084ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US208-1084US2081084A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18ÁðmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09ApmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-11B(mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-18B/mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-26B7mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BDmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17B¨mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18ÁðmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09ApmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-11B(mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-18B/mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-26B7mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BDmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2020-12-17B¨mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¨mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¨mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¨mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085B$COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B¨mRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1085US2081085B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-25BîmRNA-1273-P201SSmRNA-1273-P201-US208-1086US2081086ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US208-1086US2081086A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18ÁÀmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B&mRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B-mRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B:mRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18ÁÀmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B&mRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B-mRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B:mRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-11BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1087US2081087B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18ÁàmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B(mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B/mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B=mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18ÁàmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B(mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B/mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B=mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088BCOVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1088US2081088B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1089US2081089ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US208-1089US2081089A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-18.mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19ÁÀmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B"mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B)mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B0mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B@mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090A COVID Exposed to COVID-19 Y Y A°(õÂ$Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090A°COVID Exposed to COVID-19 Y Y AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090AÀCOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÊmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090AÐCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19ÁÀmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090AàCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-06-25Á`mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090AðCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B"mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B)mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B0mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-02B@mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-12-14B§mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCOVIDSYMParticipant COVID-19 Symptomatic N N AÀ(õÂ\(Safety Call Day 169 Unscheduled 1 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÊmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BrmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B«mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-22BímRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BrmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B CONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B!CONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B«mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B"CONTACT Contact Attempted SAFETY CALLY Y AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-22BímRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B#COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B$COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BrmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B%COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B&COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B«mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B'COVID Exposed to COVID-19 SAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-22BímRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BrmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B+COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B«mRNA-1273-P201SSmRNA-1273-P201-US208-1090US2081090B,COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AðSafety Call Day 237 PART A FOLLOW-UP 2021-02-22BímRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19ÁàmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25Á€mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A°mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B'mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B.mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B<mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19ÁàmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-25Á€mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A°mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B'mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B.mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B<mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B¬mRNA-1273-P201SSmRNA-1273-P201-US208-1091US2081091B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19ÁÐmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÌmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19ÁÐmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B,mRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B:mRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-21BÌmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1092US2081092B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÄmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19ÁÐmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B)mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B1mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B>mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093ACOVID Exposed to COVID-19 N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-30B[mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÊmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19ÁÐmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B)mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-19B1mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B>mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-09-30B[mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÊmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1093US2081093B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1094US2081094ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US208-1094US2081094A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US208-1095US2081095ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US208-1095US2081095A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US208-1096US2081096ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US208-1096US2081096A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-19.mRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22ÁmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AàmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B;mRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097ACOVID Exposed to COVID-19 N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-23B’mRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÌmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22ÁmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08A€mRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-14AàmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B;mRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-11-23B’mRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÌmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BVmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BsmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17BªmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BVmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BsmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17BªmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BVmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BsmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17BªmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BVmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BsmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17BªmRNA-1273-P201SSmRNA-1273-P201-US208-1097US2081097B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÇmRNA-1273-P201SSmRNA-1273-P201-US208-1098US2081098ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US208-1098US2081098A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B2mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B>mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099ACOVID Exposed to COVID-19 Y Y A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-11-06B†mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22Á@mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-26AmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-06A°mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29B"mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-06B*mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B2mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B>mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCOVIDSYMParticipant COVID-19 Symptomatic N N A (õÂ\(Safety Call Day 113 Unscheduled 1 PART A FOLLOW-UP 2020-11-06B†mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-14BËmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-18BUmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-16BqmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-13BmRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-11B©mRNA-1273-P201SSmRNA-1273-P201-US208-1099US2081099B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-08BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22Á mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B(mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B/mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-10BGmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÊmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22Á mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09A€mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B(mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B/mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-10BGmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BÊmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1100US2081100B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1101US2081101ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US208-1101US2081101A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US208-1102US2081102ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US208-1102US2081102A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US208-1102US2081102A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-22.mRNA-1273-P201SSmRNA-1273-P201-US208-1102US2081102A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23ÁmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103APCOVID Exposed to COVID-19 N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B2mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B>mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÍmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23ÁmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103AðCOVIDSYMParticipant COVID-19 Symptomatic Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B2mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B>mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÍmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1103US2081103B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23ÁmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104APCOVID Exposed to COVID-19 Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104A€COVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104ACOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B2mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104A COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B>mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104A°COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÍmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104AÀCOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23ÁmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCOVIDSYMParticipant COVID-19 Symptomatic N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-07-22BmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-06B$mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-13B+mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-20B2mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-01B>mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÍmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104B CONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104B!COVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104B"COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104B#COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104B$COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104B%COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104B)COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1104US2081104B*COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-14BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1105US2081105ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US208-1105US2081105A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US208-1106US2081106ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US208-1106US2081106A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US208-1107US2081107ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US208-1107US2081107A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23Á mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09ApmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B$mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B.mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B9mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108ACOVID Exposed to COVID-19 Y Y A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-16BjmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23Á mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09ApmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B$mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-17B.mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B9mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\(Safety Call Day 85 Unscheduled 1 PART A FOLLOW-UP 2020-10-16BjmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-18BÈmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1108US2081108B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1109US2081109ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US208-1109US2081109A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US208-1109US2081109A0COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23.mRNA-1273-P201SSmRNA-1273-P201-US208-1109US2081109A@COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26.mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-23Á mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A°mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B$mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B+mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B9mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÊmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-23Á mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-26ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A°mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B$mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B+mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B9mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-20BÊmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-25BUmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1110US2081110B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1111US2081111ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US208-1111US2081111A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24ÁmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A°mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-11B(mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-19B0mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-26B7mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-14BJmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-27BÑmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24ÁmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-03AmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A°mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-11B(mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-19B0mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-26B7mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-14BJmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-27BÑmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BXmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-19BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BXmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-19BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCONTACT Contact Attempted SAFETY CALLN N AðSafety Call Day 237 .mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BXmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112B COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112B!COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112B"COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-19BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BXmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-23BqmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-20BmRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-18B©mRNA-1273-P201SSmRNA-1273-P201-US208-1112US2081112B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-19BÉmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24ÁàmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-07-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-17A mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B"mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-18B*mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-24B0mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08B?mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113A COVID Exposed to COVID-19 Y Y A°(õÂ$Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-12-18B¤mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24ÁàmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ$Screening Unscheduled 1 SCREENING 2020-07-03ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113AàCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-17A mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113AðCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B"mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-18B*mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-24B0mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08B?mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCOVIDSYMParticipant COVID-19 Symptomatic N N A°(õÂ\(Safety Call Day 141 Unscheduled 1 PART A FOLLOW-UP 2020-12-18B¤mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BUmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-25BmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-21BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BUmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-25BmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-21BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BUmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-25BmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-21BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-30BUmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-28BqmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-25BmRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-23B©mRNA-1273-P201SSmRNA-1273-P201-US208-1113US2081113B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-21BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1114US2081114ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US208-1114US2081114A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US208-1115US2081115ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US208-1115US2081115A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24.mRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B&mRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B<mRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÐmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-29AmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-07AmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B&mRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-13B.mRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-27B<mRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-22BÐmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-21BUmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-19BqmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-14B©mRNA-1273-P201SSmRNA-1273-P201-US208-1116US2081116B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-11BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24ÁÀmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-25B3mRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BAmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÍmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24ÁÀmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-14AmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-18B,mRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-25B3mRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BAmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÍmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-23BmRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US208-1117US2081117B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B;mRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BËmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-31BmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-07B&mRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-14B-mRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-28B;mRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-19BËmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1118US2081118B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24ÁÀmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-19B-mRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-25B3mRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BAmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24ÁÀmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-21BmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-11B%mRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-19B-mRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-25B3mRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BAmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US208-1119US2081119B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120A COVID Exposed to COVID-19 N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-29Á mRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120A0COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120A@COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120APCOVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B+mRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B9mRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120A°COVIDSYMParticipant COVID-19 Symptomatic N N A(õÂ\)Screening Unscheduled 1 SCREENING 2020-06-29Á mRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-01AmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-09AmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-16BmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-05B$mRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-12B+mRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-26B9mRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-23BUmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-21BqmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BmRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-16B©mRNA-1273-P201SSmRNA-1273-P201-US208-1120US2081120B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-13BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-24ÁÀmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17AÀmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-24B2mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-04B=mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121ACOVID Exposed to COVID-19 N N AàVisit 8 Day 209 .mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-24ÁÀmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121A°COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-06AmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-13A€mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17AÀmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121AàCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-10B$mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121AðCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-17B+mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-24B2mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-04B=mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 .mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121B COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121B!COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-28BUmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-26BqmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-24BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-21B©mRNA-1273-P201SSmRNA-1273-P201-US208-1121US2081121B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-18BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1122US2081122ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US208-1122US2081122A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123APCOVID Exposed to COVID-19 N N A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123A`COVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123ApCOVID Exposed to COVID-19 N N A`Visit 5 Day 36 PART A FOLLOW-UP 2020-08-19B3mRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123A€COVID Exposed to COVID-19 N N ApVisit 6 Day 43 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BGmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÓmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25ÁPmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-06-30AmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08AmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-15BmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123AðCOVIDSYMParticipant COVID-19 Symptomatic Y Y A@(õÂ\(Visit 3 Day 15 Unscheduled 1 BLINDED TREATMENT 2020-07-29BmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-11B+mRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 PART A FOLLOW-UP 2020-08-19B3mRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 PART A FOLLOW-UP 2020-08-25B9mRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-09-08BGmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-26BÓmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123B"COVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-22BUmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-20BqmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-18BŽmRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-15B©mRNA-1273-P201SSmRNA-1273-P201-US208-1123US2081123B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-12BÅmRNA-1273-P201SSmRNA-1273-P201-US208-1124US2081124ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US208-1124US2081124A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B)mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125ApCOVID Exposed to COVID-19 N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B0mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125A€COVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B=mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125ACOVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125A COVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125A°COVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125AÐCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125AàCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-11B)mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125AðCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-18B0mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B=mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCOVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCOVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCOVID Exposed to COVID-19 SAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125BCOVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125B COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125B!COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125B"COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125B#COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1125US2081125B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1126US2081126ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US208-1126US2081126A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US208-1127US2081127ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US208-1127US2081127A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US208-1128US2081128ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US208-1128US2081128A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129A COVID Exposed to COVID-19 N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129A0COVID Exposed to COVID-19 N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129A@COVID Exposed to COVID-19 N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129APCOVID Exposed to COVID-19 N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129A`COVID Exposed to COVID-19 N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B(mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129ApCOVID Exposed to COVID-19 N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-10B(mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129A€COVID Exposed to COVID-19 Y Y ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-24B6mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129ACOVID Exposed to COVID-19 N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B=mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129A COVID Exposed to COVID-19 N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-28BÓmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129A°COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25ÁpmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129AÀCOVIDSYMParticipant COVID-19 Symptomatic N N A Visit 1 Day 1 BLINDED TREATMENT 2020-07-02AmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129AÐCOVIDSYMParticipant COVID-19 Symptomatic N N A0Visit 2 Day 8 BLINDED TREATMENT 2020-07-08ApmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129AàCOVIDSYMParticipant COVID-19 Symptomatic N N A@Visit 3 Day 15 BLINDED TREATMENT 2020-07-17BmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129AðCOVIDSYMParticipant COVID-19 Symptomatic N N APVisit 4 Day 29 BLINDED TREATMENT 2020-08-03B!mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCOVIDSYMParticipant COVID-19 Symptomatic N N A`Visit 5 Day 36 BLINDED TREATMENT 2020-08-10B(mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCOVIDSYMParticipant COVID-19 Symptomatic N N A`(õÂ\(Visit 5 Day 36 Unscheduled 1 BLINDED TREATMENT 2020-08-10B(mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCOVIDSYMParticipant COVID-19 Symptomatic N N ApVisit 6 Day 43 BLINDED TREATMENT 2020-08-24B6mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCOVIDSYMParticipant COVID-19 Symptomatic N N A€Visit 7 Day 57 PART A FOLLOW-UP 2020-08-31B=mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCOVIDSYMParticipant COVID-19 Symptomatic N N AàVisit 8 Day 209 PART A FOLLOW-UP 2021-01-28BÓmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCONSTAT Contact Status SAFETY CALLContact Made Contact Made ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCONSTAT Contact Status SAFETY CALLContact Made Contact Made A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCONSTAT Contact Status SAFETY CALLContact Made Contact Made AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCONTACT Contact Attempted SAFETY CALLY Y ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCONTACT Contact Attempted SAFETY CALLY Y A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCONTACT Contact Attempted SAFETY CALLY Y A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCONTACT Contact Attempted SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCONTACT Contact Attempted SAFETY CALLY Y AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129BCOVID Exposed to COVID-19 SAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129B COVID Exposed to COVID-19 SAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129B!COVID Exposed to COVID-19 SAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129B"COVID Exposed to COVID-19 SAFETY CALLY Y AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129B#COVID Exposed to COVID-19 SAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129B$COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N ASafety Call Day 85 PART A FOLLOW-UP 2020-09-24BUmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129B%COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A Safety Call Day 113 PART A FOLLOW-UP 2020-10-22BqmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129B&COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N A°Safety Call Day 141 PART A FOLLOW-UP 2020-11-19BmRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129B'COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÀSafety Call Day 169 PART A FOLLOW-UP 2020-12-17B©mRNA-1273-P201SSmRNA-1273-P201-US208-1129US2081129B(COVIDSYMParticipant COVID-19 SymptomaticSAFETY CALLN N AÐSafety Call Day 197 PART A FOLLOW-UP 2021-01-15BÆmRNA-1273-P201SSmRNA-1273-P201-US208-1130US2081130ACOVID Exposed to COVID-19 N N AScreening SCREENING 2020-06-25.mRNA-1273-P201SSmRNA-1273-P201-US208-1130US2081130A COVIDSYMParticipant COVID-19 Symptomatic N N AScreening SCREENING 2020-06-25.